No definition available.
Postprocedural endocrine and metabolic disorders, not elsewhere classified
EFO MESH Endpoint Browser PheWeb
E4_ENDOMETPOSTOP
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
5229 |
4. Check minimum number of eventsNone |
5229 |
5. Include endpointsNone |
5229 |
6. Filter based on genotype QC (FinnGen only) |
5229 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Perturbationes endocrinae et metabolicae post interventiones non alibi classificatae
Similar endpoints
↥List of similar endpoints to
Postprocedural endocrine and metabolic disorders, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Other metabolic disorders
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 24717 | 19645 | 4902 |
| Only index persons | 22223 | 17885 | 4338 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.48 | 0.56 | 0.14 |
| Only index persons | 0.56 | 0.66 | 0.17 |
| Median age at first event (years) | |||
| Whole population | 58.32 | 58.68 | 56.98 |
| Only index persons | 56.84 | 57.02 | 56.09 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5229 | 4251 | 978 |
| Unadjusted period prevalence (%) | 1.26 | 1.45 | 0.43 |
| Median age at first event (years) | 52.31 | 51.34 | 56.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4613
- Matched controls
- 46129
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
50.7
323.0
731
171
E89.2
ICD-10 Finland
Postprocedural hypoparathyroidism
2471.5
323.0
468
*
104
Kela drug reimbursment
Thyroid insufficiency
23.2
323.0
2155
1676
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
27.2
323.0
960
442
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
448.7
323.0
2007
79
H03BB01
ATC
carbimazole; oral
34.2
323.0
1628
723
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
38.3
323.0
1368
502
BAA60
NOMESCO Finland
Total thyroidectomy
69.2
323.0
1559
337
H03AA01
ATC
levothyroxine sodium; systemic
20.7
323.0
3680
7396
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
40.1
323.0
463
128
A11CC03
ATC
alfacalcidol; systemic
28.8
323.0
457
175
121
Kela drug reimbursment
Severe hypofunction of sexual glands
34.2
323.0
860
307
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
1167.1
323.0
1145
13
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
45.8
323.0
601
150
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.5
323.0
2257
9979
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.1
323.0
853
1116
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
447.1
297.6
295
7
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
9.3
281.1
622
761
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
27.2
274.7
385
154
106
Kela drug reimbursment
Hypoparathyroidism
176.1
239.6
250
15
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
19.6
233.3
362
199
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.9
209.1
1011
3120
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
49.7
208.5
254
54
E83.51
ICD-10 Finland
Hypocalcemia
245.5
206.5
211
9
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
40.7
186.3
236
61
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
8.8
163.5
368
450
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
19.1
155.2
242
133
4CJ01
NOMESCO Finland
NA
91.2
150.2
167
19
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
146.1
1506
7497
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
12.8
144.2
265
219
A11CC02
ATC
dihydrotachysterol; oral
131.8
143.0
153
12
C07AA05
ATC
propranolol; systemic
2.6
141.9
1280
5899
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
8.9
140.8
313
373
A12AA04
ATC
calcium carbonate; oral
19.1
132.9
207
113
ZX114
NOMESCO Finland
Intramuscular
11.2
130.8
256
241
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
10.4
128.2
261
265
H02AB09
ATC
hydrocortisone; systemic
9.4
127.3
273
305
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
126.5
1277
6195
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
55.8
122.6
146
27
E03.89
ICD-10 Finland
Other specified hypothyroidism
5.9
120.2
356
642
C07AB07
ATC
bisoprolol; oral
2.1
118.2
1983
12134
E89.0
ICD-10 Finland
Postprocedural hypothyroidism
126.3
114.6
123
10
T86
ICPC
Hypothyroidism/myxoedema
4.8
112.8
402
895
E89.4
ICD-10 Finland
Postprocedural ovarian failure
529.7
105.1
104
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
8.9
104.3
230
269
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
3.3
99.0
553
1826
BA1NN
NOMESCO Finland
I-131 dose capsel measurement
76.6
98.7
112
15
E03
ICD-10 Finland
Other hypothyroidism
3.6
97.4
473
1400
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
96.2
1854
11696
ZXA10
NOMESCO Finland
Bilateral
2.3
93.4
996
4850
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
8.2
90.0
209
266
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
28.4
88.9
122
44
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
64.5
86.9
101
16
WX402
NOMESCO Finland
General anaesthesia
2.3
86.2
918
4449
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.4
82.6
263
514
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
802.0
80.7
79
*
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
42.5
76.9
96
23
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
31.6
76.5
102
33
N02BE01
ATC
paracetamol; systemic, rectal
2.1
76.1
3964
34233
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
5.4
76.0
242
472
127
Kela drug reimbursment
Transplant complication
10.4
74.4
150
149
T85
ICPC
Hyperthyroidism/thyrotoxicosis
17.6
73.5
117
68
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
72.7
949
5001
2440A
ICD-9 Finland
Acquired hypothyroidism, Postsurgical hypothyroidism
+∞
72.1
69
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
33.1
69.1
91
28
N80.1
ICD-10 Finland
Endometriosis of ovary
4.2
68.9
278
694
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
16.1
68.1
112
71
H062, E050
ICD-10 Finland
NA
58.1
67.9
80
14
TPH07
NOMESCO Finland
Cathetrisation of artery
2.8
67.7
466
1753
BBA30
NOMESCO Finland
Excision of lesion of parathyroid gland
8.2
64.4
148
185
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
+∞
63.7
61
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
34.8
63.0
82
24
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
5.5
61.5
190
358
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
16.4
60.1
98
61
T71
ICPC
Malignant neoplasm thyroid
75.6
59.2
67
9
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
6.2
59.0
164
271
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
+∞
58.4
56
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
57.6
1916
13730
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
57.5
251
672
101
Kela drug reimbursment
Anterior pituitary hypofunction
20.4
57.1
86
43
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
24.2
56.8
81
34
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
16.9
56.5
91
55
XW000
NOMESCO Finland
Bone marrow biopsy
4.2
56.1
226
563
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
3.9
56.0
247
667
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
55.9
549
2511
E83.50
ICD-10 Finland
Hypercalcemia
19.9
55.3
84
43
E89.9
ICD-10 Finland
Postprocedural endocrine and metabolic disorder, unspecified
+∞
55.3
53
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
54.8
990
5839
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
53.3
2263
17201
A02BC02
ATC
pantoprazole; systemic
1.6
53.2
2837
22874
LCD00
NOMESCO Finland
Hysterectomy
3.0
53.0
331
1164
E20.8
ICD-10 Finland
Other hypoparathyroidism
85.4
53.0
59
7
H02AB06
ATC
prednisolone; systemic
1.6
52.9
2054
15231
E87.6
ICD-10 Finland
Hypokalaemia
10.5
52.4
104
101
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
49.1
52.1
63
13
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
51.9
320
1116
C03CA01
ATC
furosemide; systemic
1.9
51.0
940
5565
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
49.2
1192
7701
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
49.0
2043
15328
E04.1
ICD-10 Finland
Nontoxic single thyroid nodule
5.1
48.8
159
319
B01AB05
ATC
enoxaparin; parenteral
1.7
47.8
1293
8618
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
9.8
47.1
97
101
ZX120
NOMESCO Finland
Intravenous
2.4
47.1
453
2039
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
60.7
46.3
54
9
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
9.2
46.1
98
108
E21.0
ICD-10 Finland
Primary hyperparathyroidism
6.2
46.1
127
208
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
17.2
45.9
73
43
8341/3-C73.9
ICD-O-3
Papillary microcarcinoma of thyroid gland
101.1
45.8
50
5
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.6
45.5
215
615
Z51.88
ICD-10 Finland
Other specified medical care
5.9
45.5
132
231
C08CA01
ATC
amlodipine; oral
1.7
45.4
1230
8174
E04.0
ICD-10 Finland
Nontoxic diffuse goitre
8.5
45.3
101
121
A12AA06
ATC
calcium lactate gluconate; oral
73.8
45.0
51
7
WW200
NOMESCO Finland
Immunization
4.3
44.9
172
408
N02AX02
ATC
tramadol; systemic, rectal
1.6
44.3
1725
12618
C07AB02
ATC
metoprolol; systemic
1.9
44.1
756
4339
E23.00
ICD-10 Finland
Panhypopituitarism
23.6
44.0
63
27
R4110
NOMESCO Finland
Physiotherapy
1.7
43.9
1120
7305
WX704
NOMESCO Finland
Intubation
2.4
42.5
375
1613
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
6.1
42.4
119
200
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
41.9
487
2392
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
41.5
550
2857
BBA70
NOMESCO Finland
Implantation or transplantation of parathyroid gland
42.9
41.3
51
12
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
40.6
357
1531
ZXA00
NOMESCO Finland
Right side
1.7
40.5
1096
7243
WZC30
NOMESCO Finland
Teaching
2.0
39.9
568
3033
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
39.8
639
3570
A05AA02
ATC
ursodeoxycholic acid; oral
4.7
39.5
138
299
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
38.9
246
870
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
38.5
1438
10315
P01AB01
ATC
metronidazole; oral, rectal
1.5
37.4
1819
13856
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
36.6
685
4027
R50.9
ICD-10 Finland
Fever, unspecified
1.9
36.5
576
3192
L04AD01
ATC
ciclosporin; systemic
4.6
35.8
129
289
H01AC01
ATC
somatropin; parenteral
48.2
35.6
43
9
A10AE04
ATC
insulin glargine; parenteral
2.4
35.6
319
1380
8330/3-C73.9
ICD-O-3
Follicular carcinoma, NOS, of thyroid gland
26.9
35.0
48
18
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
5.4
34.9
107
201
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.1
34.8
97
162
105
Kela drug reimbursment
Adrenal cortical hypofunction
23.0
34.8
50
22
BAA25
NOMESCO Finland
Bilateral partial excision of thyroid gland
20.2
34.8
52
26
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
34.3
1551
11554
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.6
34.3
272
1103
E86
ICD-10 Finland
Volume depletion
29.0
34.2
46
16
UJF32
NOMESCO Finland
Coloscopy
1.6
33.4
1002
6755
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
33.2
563
3194
J01DB01
ATC
cefalexin; oral
1.5
33.1
3610
32259
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
33.0
396
1964
R53
ICD-10 Finland
Malaise and fatigue
1.7
33.0
829
5319
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
3.0
32.8
199
684
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
6.7
32.3
84
128
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
+∞
32.3
31
*
2506
FHL
Thyroidectomy
20.2
32.1
48
24
N02AA05
ATC
oxycodone; systemic
1.9
32.0
510
2827
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.7
31.8
110
237
R06.0
ICD-10 Finland
Dyspnoea
1.6
31.6
926
6194
2505
FHL
Bilateral resection (also used if total removal has been performed on the other side)
7.2
31.4
77
108
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
14.5
31.4
53
37
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
5.4
31.3
96
181
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.6
31.2
233
913
WW500
NOMESCO Finland
Blood transfusion
3.0
31.0
185
630
JN4BD
NOMESCO Finland
Extensive body CT
2.0
30.8
420
2194
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
30.7
705
4401
A02BC05
ATC
esomeprazole; systemic
1.5
30.7
1720
13329
C10AA05
ATC
atorvastatin; oral
1.5
30.7
1140
8076
E20.9
ICD-10 Finland
Hypoparathyroidism, unspecified
35.7
30.5
39
11
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
14.7
30.4
51
35
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
30.4
672
4148
A02BC01
ATC
omeprazole; systemic
1.6
30.4
1105
7789
AA1AD
NOMESCO Finland
CT of head and brain
1.6
30.1
805
5243
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
30.0
928
6278
N03AX16
ATC
pregabalin; oral
1.6
30.0
961
6565
SPAT1262
SPAT
Handing over of treatment supplies
1.7
29.6
623
3783
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
29.6
284
1273
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
15.6
29.4
48
31
WX110
NOMESCO Finland
Local anesthesy
1.4
29.2
2979
25804
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
2.3
29.2
278
1240
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
7.7
29.1
68
89
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
29.1
939
6419
N05CF01
ATC
zopiclone; oral
1.5
29.0
1276
9369
C73.94
ICD-10 Finland
Medullary thyroid carcinoma (thyroid)
293.7
28.8
29
*
N80.9
ICD-10 Finland
Endometriosis, unspecified
3.7
28.7
131
366
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
8.0
28.5
65
82
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
9.9
28.3
57
58
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
28.2
314
1505
E05.89
ICD-10 Finland
Other thyrotoxicosis
14.8
28.2
47
32
E8901, C7391
ICD-10 Finland
NA
+∞
28.1
27
*
H02AA02
ATC
fludrocortisone; oral
8.7
28.1
61
71
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
28.0
1402
10565
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
27.6
811
5404
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
27.5
758
4966
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
47.4
27.4
33
7
24199
ICD-8 Finland
Non-toxic nodular goitre, Unspecified
5.9
27.4
78
135
N80.5
ICD-10 Finland
Endometriosis of intestine
9.0
27.4
58
65
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
27.3
450
2520
E21.3
ICD-10 Finland
Hyperparathyroidism, unspecified
5.8
27.1
78
137
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
27.0
156
521
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
27.0
546
3270
L03AA02
ATC
filgrastim; parenteral
3.1
26.7
149
486
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
26.5
459
2612
1930A
ICD-9 Finland
Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]
20.7
26.5
39
19
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
6.0
26.4
74
126
G47.3
ICD-10 Finland
Sleep apnoea
1.6
26.2
713
4648
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
18.3
26.1
40
22
BAA50
NOMESCO Finland
Lobectomy and resection of contralateral lobe of thyroid gland
19.6
26.0
39
20
WX892
NOMESCO Finland
Monitored bed care
2.3
26.0
259
1180
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
25.8
662
4246
E05.5
ICD-10 Finland
Thyroid crisis or storm
73.1
25.8
29
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
25.6
261
1201
8340/3-C73.9
ICD-O-3
Papillary carcinoma, follicular variant of thyroid gland
33.2
25.5
33
10
N03AX12
ATC
gabapentin; oral
1.7
25.3
619
3918
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.2
25.3
137
438
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
25.3
345
1802
ZXA05
NOMESCO Finland
Left side
1.5
25.3
966
6839
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
25.2
310
1550
F64.0
ICD-10 Finland
Transsexualism
20.7
25.1
37
18
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
8.0
25.1
57
72
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
9.9
24.9
50
51
Z71.8
ICD-10 Finland
Other specified counselling
1.5
24.9
975
6937
WX002
NOMESCO Finland
Sedation and analgesia
1.6
24.9
760
5099
L28
ICPC
Limited function/disability (L)
1.7
24.8
538
3285
H02AB04
ATC
methylprednisolone; systemic
1.7
24.5
610
3878
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.7
24.4
599
3793
N05BA04
ATC
oxazepam; oral
1.5
24.3
1006
7241
19399
ICD-8 Finland
Malignant neoplasm of thyroid gland
48.6
24.3
29
6
T90
ICPC
Diabetes non-insulin dependent
1.6
24.1
697
4609
C10AA01
ATC
simvastatin; oral
1.5
24.1
1216
9119
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
13.8
24.0
41
30
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
23.9
213
918
H03BA02
ATC
propylthiouracil; oral
25.5
23.9
33
13
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.8
23.7
416
2377
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
16.0
23.6
38
24
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
41.6
23.6
29
7
C03DA01
ATC
spironolactone; oral
2.0
23.4
322
1683
C10AA07
ATC
rosuvastatin; oral
1.6
23.4
753
5113
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
23.4
711
4759
205
Kela drug reimbursment
Chronic hypertension
1.5
23.3
811
5607
A04
ICPC
Weakness/tiredness general
1.7
23.2
487
2945
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.0
23.2
297
1509
A04AA01
ATC
ondansetron; systemic, rectal
2.0
23.0
300
1536
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
4.2
22.8
87
209
M04AA01
ATC
allopurinol; systemic
2.0
22.7
317
1667
D34
ICD-10 Finland
Benign neoplasm of thyroid gland
5.7
22.7
66
118
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.6
22.5
174
697
C09CA01
ATC
losartan; oral
1.5
22.4
809
5633
H53.2
ICD-10 Finland
Diplopia
2.9
22.3
139
489
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
6.8
22.2
56
83
S18
ICPC
Laceration/cut
1.4
22.1
1573
12528
B01AC04
ATC
clopidogrel; oral
1.9
22.1
343
1874
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.6
22.0
170
680
B01AB10
ATC
tinzaparin; parenteral
2.0
22.0
274
1379
GD1AD
NOMESCO Finland
Thorax CT examination
2.5
22.0
171
689
J01MA12
ATC
levofloxacin; systemic
1.6
21.7
639
4236
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
21.5
1854
15225
E04.8
ICD-10 Finland
Other specified nontoxic goitre
9.4
21.5
44
47
R13
ICD-10 Finland
Dysphagia
2.1
21.2
239
1153
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
21.1
164
658
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
21.1
953
6960
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
15.5
21.0
34
22
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.4
20.9
101
298
R42
ICD-10 Finland
Dizziness and giddiness
1.5
20.9
795
5598
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
20.9
955
6987
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.6
20.9
562
3640
E89.39
ICD-10 Finland
Postprocedural hypopituitarism, other or several procedures
+∞
20.8
20
*
102
Kela drug reimbursment
Diabetes insipidus
17.9
20.8
32
18
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
20.7
651
4382
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.7
20.7
140
519
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
20.6
245
1210
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
4.0
20.5
82
206
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.8
20.4
389
2278
XF404
NOMESCO Finland
Ambulatory ECG
1.9
20.3
307
1664
B01AA03
ATC
warfarin; systemic
1.6
20.2
522
3343
J01FF01
ATC
clindamycin; systemic
1.4
20.2
1047
7845
WX720
NOMESCO Finland
Own respiration
2.5
20.2
162
663
T89
ICPC
Diabetes insulin dependent
2.6
20.1
147
569
A28
ICPC
Limited function/disability NOS
1.7
20.1
432
2627
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.0
20.0
275
1437
E06.3
ICD-10 Finland
Autoimmune thyroiditis
5.6
20.0
58
104
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
20.0
258
1316
J01MA02
ATC
ciprofloxacin; systemic
1.4
19.9
1444
11488
G03DC03
ATC
lynestrenol; oral
2.7
19.8
138
520
24210
ICD-8 Finland
Thyrotoxicosis with or without goitre, Toxic nodular goitre
12.6
19.8
35
28
R51.80
ICD-10 Finland
Headache
1.6
19.7
605
4043
E24.0
ICD-10 Finland
Pituitary-dependent Cushing disease
73.8
19.7
22
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
6.1
19.6
53
87
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.0
19.6
118
406
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.1
19.5
231
1138
E87.5
ICD-10 Finland
Hyperkalaemia
13.8
19.5
33
24
JN5SN
NOMESCO Finland
NA
40.2
19.5
24
6
R11
ICD-10 Finland
Nausea and vomiting
1.9
19.4
302
1650
A10AE05
ATC
insulin detemir; parenteral
2.3
19.4
184
822
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
19.3
529
3437
2420A
ICD-9 Finland
Thyrotoxicosis with or without goitre, Toxic diffuse goitre
15.6
19.2
31
20
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
12.2
19.0
34
28
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
19.0
1472
11815
A02BC03
ATC
lansoprazole; oral
1.4
19.0
1123
8611
N80.8
ICD-10 Finland
Other endometriosis
7.3
18.9
45
62
E66.8
ICD-10 Finland
Other obesity
2.1
18.9
226
1118
JAH00
NOMESCO Finland
Laparotomy
2.9
18.8
117
414
J02AC01
ATC
fluconazole; systemic
1.3
18.8
1944
16315
A09AA02
ATC
multienzymes (lipase, protease etc.)
3.6
18.7
84
234
XF402
NOMESCO Finland
ECG with work load test
1.8
18.7
335
1925
2504
FHL
Unilateral resection or enucleation
5.4
18.7
56
105
N06AX11
ATC
mirtazapine; oral
1.4
18.6
1250
9786
TFP20
NOMESCO Finland
Cardiodefibrillation
2.2
18.6
201
952
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
18.6
305
1700
R02
ICPC
Shortness of breath/dyspnoea
1.7
18.5
420
2593
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
18.5
197
926
130
Kela drug reimbursment
Malignant tumour
1.9
18.4
259
1367
J01DA01
ATC
[U] cefalexin; systemic
1.3
18.4
2653
23345
C09AA05
ATC
ramipril; oral
1.5
18.4
675
4701
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
18.4
1453
11685
128
Kela drug reimbursment
Cancers of female genital organs
3.1
18.4
101
329
TK800
NOMESCO Finland
Hemodialysis
4.1
18.3
72
179
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
2.1
18.0
218
1086
N97.8
ICD-10 Finland
Female infertility of other origin
3.1
18.0
101
334
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.6
18.0
132
516
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
17.9
398
2441
H50.2
ICD-10 Finland
Vertical strabismus
5.7
17.9
51
90
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
17.8
500
3268
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
5.7
17.8
51
91
301
Kela drug reimbursment
Growth hormone
66.8
17.7
20
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
20.1
17.7
26
13
E29.1
ICD-10 Finland
Testicular hypofunction
7.3
17.7
42
58
BBA20
NOMESCO Finland
Exploration of parathyroid gland
8.5
17.6
38
45
JAH01
NOMESCO Finland
Laparoscopy
2.0
17.6
219
1102
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
4.0
17.6
70
176
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
17.5
193
922
R49.08
ICD-10 Finland
Other specified dysphonia
2.8
17.5
111
396
ZX108
NOMESCO Finland
Inhalation
7.2
17.5
42
59
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
5.8
17.5
49
85
J01AA02
ATC
doxycycline; systemic
1.3
17.5
3339
30501
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
42.1
17.3
21
5
H05.2
ICD-10 Finland
Exophthalmic conditions
9.8
17.1
34
35
M79.6
ICD-10 Finland
Pain in limb
1.3
17.0
1379
11104
BWD00
NOMESCO Finland
Reoperation for deep haemorrhage in endocrine surgery
25.7
16.9
23
9
BCA30
NOMESCO Finland
Unilateral adrenalectomy
21.9
16.8
24
11
A02BA02
ATC
ranitidine; systemic
1.5
16.8
709
5077
R06AE07
ATC
cetirizine; oral
1.3
16.8
1867
15742
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
16.8
388
2405
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
16.7
1157
9078
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
16.7
397
2480
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
16.6
468
3057
24209
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffuse NUD
15.1
16.6
27
18
Z01.7
ICD-10 Finland
Laboratory examination
1.6
16.6
411
2598
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
16.6
299
1721
L04AA06
ATC
mycophenolic acid; systemic
3.7
16.5
73
202
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
16.5
310
1808
C739
ICD-10 Finland
NA
27.6
16.5
22
8
N18.8
ICD-10 Finland
Other chronic renal failure
3.6
16.4
73
203
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
16.4
400
2517
R03AC02
ATC
salbutamol; inhalant
1.3
16.4
2171
18743
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
16.3
282
1602
BBA50
NOMESCO Finland
Total parathyroidectomy
40.2
16.3
20
5
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
4.1
16.3
63
155
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
16.3
478
3157
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.1
16.3
29
24
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
3.4
16.3
80
241
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
16.2
186
904
SPAT1153
SPAT
Removal of sutures
1.4
16.2
1173
9263
CA1AD
NOMESCO Finland
Orbita CT
11.2
16.2
30
27
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
3.3
16.2
80
242
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.7
16.1
360
2212
C08CA02
ATC
felodipine; oral
1.8
16.1
265
1483
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
16.0
454
2971
N06AX21
ATC
duloxetine; oral
1.6
16.0
441
2867
E21.2
ICD-10 Finland
Other hyperparathyroidism
8.2
16.0
35
43
A07AA02
ATC
nystatin; oral
1.9
15.8
243
1324
E06.2
ICD-10 Finland
Chronic thyroiditis with transient thyrotoxicosis
33.5
15.7
20
6
L02AE02
ATC
leuprorelin; implant, parenteral
2.5
15.7
122
494
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
15.7
892
6758
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
4.9
15.6
51
106
C08CA13
ATC
lercanidipine; oral
1.6
15.6
407
2607
E89.31
ICD-10 Finland
Postirradiation hypopituitarism
+∞
15.6
15
*
C02AC05
ATC
moxonidine; oral
2.4
15.6
129
538
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.2
15.6
83
266
C03AA03
ATC
hydrochlorothiazide; oral
1.8
15.5
298
1750
H02AB07
ATC
prednisone; oral
1.5
15.5
546
3760
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.3
15.5
57
134
JN4AD
NOMESCO Finland
Body CT examination
1.9
15.5
245
1350
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.5
15.4
54
121
J01FA09
ATC
clarithromycin; systemic
1.3
15.4
1313
10620
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
15.3
325
1966
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
15.3
533
3660
R4130
NOMESCO Finland
Speech therapy
3.1
15.3
85
281
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
15.2
358
2229
N06AX16
ATC
venlafaxine; oral
1.5
15.2
570
3977
Z31.5
ICD-10 Finland
Genetic counselling
1.9
15.1
234
1278
L04AA01
ATC
[U] ciclosporin; systemic
3.3
15.1
76
234
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
15.1
253
1424
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.0
15.1
206
1078
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
15.0
324
1970
XCK00
NOMESCO Finland
Perimetry
1.8
15.0
241
1335
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
15.0
1221
9797
J01FA10
ATC
azithromycin; systemic
1.3
15.0
2523
22364
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
4.4
15.0
54
125
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
5.2
14.9
46
90
A06AD11
ATC
lactulose; oral
1.6
14.8
427
2806
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.7
14.8
328
2012
A10BA02
ATC
metformin; oral
1.4
14.7
780
5828
KFC00
NOMESCO Finland
Unilateral orchiectomy
10.4
14.7
28
27
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
14.7
1538
12793
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.7
14.6
100
377
C07AA07
ATC
sotalol; systemic
2.5
14.6
111
445
CAC44
NOMESCO Finland
Combined decompression of orbit
80.3
14.6
16
*
R4190
NOMESCO Finland
Nutritional therapy
2.4
14.5
125
533
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
6.7
14.5
36
54
WW300
NOMESCO Finland
Transfer of autologic stem cells
7.3
14.4
34
47
BAA99
NOMESCO Finland
Other operation on thyroid gland
36.1
14.4
18
5
R49.01
ICD-10 Finland
Functional dysphonia
2.2
14.4
141
639
ZX121
NOMESCO Finland
Central venous catheter
7.8
14.3
32
41
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
14.3
352
2221
E24.9
ICD-10 Finland
Cushing syndrome, unspecified
27.2
14.3
19
7
R00.2
ICD-10 Finland
Palpitations
1.7
14.1
280
1660
R60.0
ICD-10 Finland
Localized oedema
1.6
14.1
354
2243
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
14.1
250
1433
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
14.1
210
1133
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.5
14.1
114
472
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
5.6
14.0
40
72
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.8
13.9
235
1323
IBZ08
NOMESCO Finland
Gender identity assessment
15.8
13.9
22
14
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.2
13.9
148
700
207
Kela drug reimbursment
Chronic arrhythmias
1.6
13.9
348
2204
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.1
13.8
160
785
T99
ICPC
Endocr/metab/nutrit disease other
3.4
13.8
67
201
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
13.8
198
1055
2419X
ICD-9 Finland
Non-toxic nodular goitre, Unspecified non-toxic nodular goitre
6.5
13.8
35
54
BAA20
NOMESCO Finland
Unilateral partial excision of thyroid gland
7.8
13.8
31
40
CAC30
NOMESCO Finland
Decompression of orbit to sinuses
53.5
13.8
16
*
N06AA09
ATC
amitriptyline; systemic
1.6
13.8
363
2330
G44.2
ICD-10 Finland
Tension-type headache
1.5
13.8
539
3794
C10AX09
ATC
ezetimibe; oral
1.8
13.7
260
1520
J01FA06
ATC
roxithromycin; oral
1.3
13.7
1643
13882
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
13.6
420
2802
J05AB11
ATC
valaciclovir; oral
1.5
13.6
516
3606
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.1
13.6
156
763
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
6.1
13.6
36
59
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
13.6
836
6402
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
13.5
2063
17959
E89.8
ICD-10 Finland
Other postprocedural endocrine and metabolic disorders
+∞
13.5
13
*
UKC02
NOMESCO Finland
Cystoscopy
1.5
13.5
431
2899
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
13.5
241
1383
WA039
NOMESCO Finland
Radiotherapy with free isotopes
140.4
13.4
14
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.2
13.4
50
120
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
13.3
535
3785
XCD10
NOMESCO Finland
Electrophysiological examination of eye
2.5
13.3
100
399
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
13.3
1537
12910
UDQ02
NOMESCO Finland
Direct laryngoscopy
4.7
13.2
44
95
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
13.1
182
957
L02AE03
ATC
goserelin; implant
3.3
13.1
64
194
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
2.1
13.0
151
739
TAB00
NOMESCO Finland
Lumbar puncture
2.0
13.0
177
922
L17
ICPC
Foot/toe symptom/complaint
1.3
13.0
908
7092
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
13.0
660
4886
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
13.0
312
1957
E22.0
ICD-10 Finland
Acromegaly and pituitary gigantism
16.7
13.0
20
12
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
12.9
106
441
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
12.9
477
3314
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
12.9
112
481
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.5
12.9
59
170
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
12.8
339
2178
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
12.8
348
2250
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
12.8
179
945
RD210
NOMESCO Finland
NA
2.9
12.7
75
259
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.5
12.7
58
167
A01AB09
ATC
miconazole; local oral
1.6
12.7
340
2194
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.8
12.6
41
86
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
15.4
12.6
20
13
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
15.4
12.6
20
13
AN1
HP
Coronary angiography
1.7
12.6
238
1393
J01CA04
ATC
amoxicillin; systemic
1.3
12.6
3479
32446
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.4
12.5
105
445
2411A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic multinodular goitre
6.1
12.5
33
54
3025
Kela drug reimbursment
Calcium carbonate
17.3
12.5
19
11
8345/3-C73.9
ICD-O-3
Medullary thyroid carcinoma of thyroid gland
130.3
12.4
13
*
Y28
ICPC
Limited function/disability (Y)
13.2
12.4
21
16
N80.0
ICD-10 Finland
Endometriosis of uterus
2.3
12.4
117
524
E66.01
ICD-10 Finland
Obesity due to excess calories
1.6
12.3
296
1857
R03DC03
ATC
montelukast; oral
1.4
12.2
643
4784
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
4.4
12.2
43
98
E05.4
ICD-10 Finland
Thyrotoxicosis factitia
14.3
12.2
20
14
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.8
12.2
80
293
WW409
NOMESCO Finland
Other aferesis
9.0
12.2
25
28
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
9.0
12.2
25
28
M03BX02
ATC
tizanidine; oral
1.3
12.2
2616
23597
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.8
12.2
211
1202
PJD99
NOMESCO Finland
Excision of other lymph nodes
15.9
12.1
19
12
R03BA01
ATC
beclometasone; inhalant
1.4
12.1
538
3883
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.6
12.1
54
153
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
12.1
219
1266
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
12.0
399
2706
24220
ICD-8 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre
26.7
12.0
16
6
E24.8
ICD-10 Finland
Other Cushing syndrome
26.7
12.0
16
6
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
8.2
12.0
26
32
C10AA03
ATC
pravastatin; oral
1.9
12.0
179
969
DQE10
NOMESCO Finland
Injection of foreign material into vocal cord
8.7
12.0
25
29
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
12.0
1020
8195
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.5
12.0
379
2544
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
11.9
314
2017
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
13.4
11.9
20
15
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.6
11.9
291
1832
D35.30
ICD-10 Finland
Craniopharyngoma
46.8
11.9
14
*
N06AB10
ATC
escitalopram; oral
1.4
11.9
788
6099
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
11.8
541
3924
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.2
11.8
118
542
E0000UV
ATC
NA
1.3
11.8
1547
13149
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
11.8
251
1520
C01BD01
ATC
amiodarone; systemic
2.8
11.8
73
259
T81
ICPC
Goitre
6.1
11.8
31
51
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
8.4
11.8
25
30
A10AA02
ATC
NA
2.2
11.7
111
500
C09DA01
ATC
losartan and diuretics; oral
1.6
11.7
307
1968
8442/1-C56.9
ICD-O-3
Serous borderline tumor, NOS, of ovary
6.6
11.7
29
44
R52.9
ICD-10 Finland
Pain, unspecified
1.6
11.7
284
1787
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
11.6
300
1917
SPAT1254
SPAT
Administration of medicine
1.5
11.6
462
3257
SPAT1263
SPAT
Sampling
1.3
11.6
1623
13899
BB1BQ
NOMESCO Finland
Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT
6.0
11.6
31
52
24200
ICD-8 Finland
Thyrotoxicosis with or without goitre, Cum struma diffusa et exophthalmo. Morbus Basedowi
12.5
11.6
20
16
GB1AA
NOMESCO Finland
Tracheal X-ray examination
12.5
11.6
20
16
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
65.1
11.6
13
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
65.1
11.6
13
*
E89
ICD-10 Finland
Postprocedural endocrine and metabolic disorders, not elsewhere classified
65.1
11.6
13
*
E20
ICD-10 Finland
Hypoparathyroidism
65.1
11.6
13
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
2.8
11.6
73
264
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
2.0
11.6
149
764
E20.0
ICD-10 Finland
Idiopathic hypoparathyroidism
18.9
11.6
17
9
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
22.9
11.6
16
7
6171A
ICD-9 Finland
Endometriosis of ovary
2.8
11.5
74
271
B01AF02
ATC
apixaban; oral
1.7
11.5
237
1424
R52.2
ICD-10 Finland
Other chronic pain
2.1
11.5
126
603
B01AB04
ATC
dalteparin; parenteral
1.9
11.5
169
909
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
11.5
919
7310
J02AC03
ATC
voriconazole; systemic
10.0
11.5
22
22
2513A
ICD-9 Finland
Other disorders of pancreatic internal secretion, Postsurgical hypoinsulinaemia
+∞
11.5
11
*
8510/3-C73.9
ICD-O-3
Medullary carcinoma, NOS, of thyroid gland
+∞
11.5
11
*
E06.9
ICD-10 Finland
Thyroiditis, unspecified
5.9
11.4
31
53
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
13.6
11.4
19
14
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
13.6
11.4
19
14
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
11.4
254
1560
JAL31
NOMESCO Finland
Laparoscopic omentectomy
6.7
11.4
28
42
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.5
11.4
26
35
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.9
11.4
66
226
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
11.4
162
863
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
11.3
809
6327
C10AC01
ATC
colestyramine; oral
2.3
11.3
102
449
WW402
NOMESCO Finland
Leucoferesis
11.8
11.3
20
17
107
Kela drug reimbursment
Pernicious anaemia
2.8
11.2
70
250
L91.0
ICD-10 Finland
Hypertrophic scar
3.1
11.2
60
196
UJD02
NOMESCO Finland
Gastroscopy
1.9
11.2
160
853
E23.03
ICD-10 Finland
Lack of ACTH
12.7
11.1
19
15
R01AD09
ATC
mometasone; nasal
1.2
11.1
1881
16447
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.2
11.1
41
99
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.2
11.0
113
527
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.9
11.0
161
867
HA1AA
NOMESCO Finland
X-ray mammography
1.6
11.0
325
2149
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.9
11.0
155
825
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
10.9
333
2215
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
43.4
10.9
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
10.9
156
832
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.4
10.9
93
398
WX882
NOMESCO Finland
High dependency care
2.5
10.9
81
324
N05BA01
ATC
diazepam; systemic, rectal
1.4
10.8
456
3253
TPH00
NOMESCO Finland
Phlebotomy
8.8
10.7
22
25
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
10.7
438
3106
N19
ICD-10 Finland
Unspecified kidney failure
2.7
10.7
73
278
E27.2
ICD-10 Finland
Addisonian crisis
28.1
10.7
14
5
H50.6
ICD-10 Finland
Mechanical strabismus
17.8
10.7
16
9
E23.09
ICD-10 Finland
Pituitary insufficiency NOS
17.8
10.7
16
9
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.1
10.6
115
550
CA1BM
NOMESCO Finland
Eye and orbita MRI examination with 3 Tesla magnet
60.1
10.6
12
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.9
10.6
152
813
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.2
10.6
108
505
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
10.6
173
968
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
6.3
10.6
27
43
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
8.5
10.5
22
26
R2110
NOMESCO Finland
Giving the first information
1.6
10.5
289
1876
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
9.2
10.5
21
23
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
10.5
390
2713
I50.0
ICD-10 Finland
Congestive heart failure
1.9
10.5
141
739
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
10.4
172
966
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
10.4
1519
13028
E89.3
ICD-10 Finland
Postprocedural hypopituitarism
+∞
10.4
10
*
BCA41
NOMESCO Finland
Endoscopic bilateral adrenalectomy
+∞
10.4
10
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
10.4
10
*
A10BH05
ATC
linagliptin; oral
2.1
10.4
109
516
F29
ICPC
Eye symptom/complaint other
1.6
10.4
291
1902
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.5
10.4
46
131
E66.00
ICD-10 Finland
Metabolic syndrome
1.9
10.4
148
792
J01EA01
ATC
trimethoprim; systemic
1.3
10.3
1017
8311
2AX04
NOMESCO Finland
NA
16.1
10.3
16
10
24400
ICD-8 Finland
Myxoedema, (hypothyreosis) post therapiam
16.1
10.3
16
10
LCA06
NOMESCO Finland
Biopsy of endometrium
1.4
10.3
532
3939
B81
ICPC
Anaemia vit B12/folate deficiency
2.1
10.3
115
558
A08
ICPC
Swelling
1.9
10.3
139
727
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
10.3
443
3176
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.9
10.3
40
102
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
10.2
97
437
C09CA06
ATC
candesartan; oral
1.3
10.2
737
5770
N80.89
ICD-10 Finland
Endometriosis with other specified or multiple localization
4.6
10.1
34
75
SPAT1325
SPAT
Vaccination
1.3
10.1
1190
9948
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.9
10.1
60
211
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.4
10.1
416
2958
SPAT1301
SPAT
No procedures
1.3
10.0
1124
9335
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
10.0
896
7226
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
10.0
137
722
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.6
10.0
230
1426
J46
ICD-10 Finland
Status asthmaticus
2.2
10.0
103
483
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
10.0
691
5368
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
10.0
1059
8735
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
10.0
1094
9063
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
10.0
322
2173
UDC00
NOMESCO Finland
Ear microscopy
1.6
9.9
244
1540
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.9
9.9
140
743
KBV10
NOMESCO Finland
Removal of stent from ureter
4.2
9.9
36
86
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.7
9.9
201
1206
M05BX04
ATC
denosumab; parenteral
1.8
9.9
167
946
M54.5
ICD-10 Finland
Low back pain
1.3
9.9
1231
10352
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.5
9.9
366
2546
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.4
9.9
78
323
321
Kela drug reimbursment
Paricalcitol and cinacalcet
7.6
9.9
22
29
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.9
9.9
134
705
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.9
9.9
146
792
H01CB02
ATC
octreotide; parenteral
8.1
9.8
21
26
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
2.0
9.8
123
628
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.5
9.8
71
281
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
3.9
9.8
38
97
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
9.8
135
714
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.5
9.8
293
1942
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
10.6
9.8
18
17
M14.5*E03.9
ICD-10 Finland
Arthropathy in hypothyroidism (E00-E03+)
8.7
9.8
20
23
D07AA02
ATC
hydrocortisone; topical
1.4
9.8
491
3618
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.7
9.7
196
1172
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
9.7
94
430
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
9.7
243
1546
Z50.5
ICD-10 Finland
Speech therapy
3.0
9.6
55
187
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
9.6
446
3244
R21
ICPC
Throat symptom/complaint
1.3
9.5
779
6202
SPAT1097
SPAT
Recording of ECG
1.4
9.5
457
3341
H50.8
ICD-10 Finland
Other specified strabismus
9.1
9.5
19
21
RS221
NOMESCO Finland
NA
2.9
9.5
56
196
2410A
ICD-9 Finland
Non-toxic nodular goitre, Non-toxic uninodular goitre
6.0
9.5
25
42
A01
ICPC
Pain general/multiple sites
1.6
9.5
258
1671
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
3.8
9.5
38
100
A10AA01
ATC
NA
2.2
9.5
89
401
K80
ICPC
Cardiac arrhythmia NOS
1.6
9.4
239
1524
E85.9
ICD-10 Finland
Amyloidosis, unspecified
100.2
9.4
10
*
E05.3
ICD-10 Finland
Thyrotoxicosis from ectopic thyroid tissue
100.2
9.4
10
*
CAC20
NOMESCO Finland
Lateral decompression of orbit
30.1
9.4
12
*
24110
ICD-8 Finland
Non-toxic nodular goitre, Sporadic
7.5
9.4
21
28
E06.0
ICD-10 Finland
Acute thyroiditis
7.5
9.4
21
28
R10.0
ICD-10 Finland
Acute abdomen
2.1
9.4
108
531
XX1MN
NOMESCO Finland
Isotope examination with measurement
+∞
9.4
9
*
2572A
ICD-9 Finland
Testicular dysfunction, Other testicular hypofunction
+∞
9.4
9
*
R01AD08
ATC
fluticasone; nasal
1.3
9.4
1143
9580
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
9.3
464
3411
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
21.7
9.3
13
6
J02AC04
ATC
posaconazole; systemic
21.7
9.3
13
6
C01DA14
ATC
isosorbide mononitrate; oral
1.5
9.3
273
1801
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.5
9.3
71
289
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
9.3
1763
15512
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
9.3
116
589
M25.5
ICD-10 Finland
Pain in joint
1.3
9.3
1085
9047
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
9.2
962
7909
N06AB03
ATC
fluoxetine; oral
1.4
9.2
458
3368
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.6
9.2
258
1685
C08DB01
ATC
diltiazem; oral
1.9
9.2
130
694
SPAT1255
SPAT
Intravenous administration of medicine
1.7
9.1
205
1263
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
7.7
9.1
20
26
LCD30
NOMESCO Finland
Radical hysterectomy
8.3
9.0
19
23
J01MA14
ATC
moxifloxacin; systemic
1.5
9.0
295
1997
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
9.0
9.0
18
20
K02.1
ICD-10 Finland
Caries of dentine
1.2
9.0
2254
20364
LEB00
NOMESCO Finland
Biopsy of vagina
2.3
9.0
81
360
N05AH04
ATC
quetiapine; oral
1.3
8.9
564
4318
GD6AD
NOMESCO Finland
CT of chest and neck
6.5
8.9
22
34
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
5.0
8.9
27
54
A10BH01
ATC
sitagliptin; oral
1.6
8.9
230
1471
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.9
8.9
52
181
C10AA04
ATC
fluvastatin; oral
1.7
8.9
196
1201
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.3
8.9
31
72
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.2
8.9
83
375
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
5.5
8.9
25
46
A27
ICPC
Fear of other disease NOS
1.8
8.9
145
815
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
8.9
1484
12871
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.1
8.8
93
443
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
7.9
8.8
19
24
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.7
8.8
60
228
D01
ICPC
Abdominal pain/cramps general
1.4
8.8
368
2622
M01AX17
ATC
nimesulide; oral
1.3
8.8
875
7144
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
8.8
591
4570
N05CF02
ATC
zolpidem; oral
1.3
8.8
665
5233
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
8.7
591
4571
A98
ICPC
Health maint/preventive medicine
1.5
8.7
4355
42434
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
5.3
8.7
25
47
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
8.7
607
4717
R55
ICD-10 Finland
Syncope and collapse
1.5
8.7
291
1979
R03BA02
ATC
budesonide; inhalant
1.3
8.7
651
5114
5604
FHL
Vascular preparation or cannulation in the operating room
14.0
8.7
14
10
T86.9
ICD-10 Finland
Failure and rejection of unspecified transplanted organ and tissue
50.1
8.7
10
*
CBK00
NOMESCO Finland
Myotomy or resection of tarsal muscle or levator muscle of eyelid for correction of retraction
50.1
8.7
10
*
C09AA02
ATC
enalapril; systemic
1.4
8.7
519
3939
J05AB01
ATC
aciclovir; systemic
1.3
8.6
826
6707
A97
ICPC
No disease
1.4
8.6
475
3557
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.5
8.6
64
258
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
7.6
8.6
19
25
E23.2
ICD-10 Finland
Diabetes insipidus
7.6
8.6
19
25
E06.1
ICD-10 Finland
Subacute thyroiditis
3.5
8.6
38
109
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.8
8.6
689
8491
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.5
8.6
287
1952
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.4
8.6
72
308
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
8.5
257
1710
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
8.5
204
1281
E28.3
ICD-10 Finland
Primary ovarian failure
4.8
8.5
27
57
RL210
NOMESCO Finland
NA
4.8
8.5
27
57
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
8.5
326
2285
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
8.5
300
2066
H03BB02
ATC
thiamazole; oral
20.0
8.5
12
6
-50
ICPC
Medication/prescr/renewal
1.8
8.5
138
776
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.4
8.5
71
303
R03BB04
ATC
tiotropium bromide; inhalant
1.5
8.4
257
1711
A03DA02
ATC
pitofenone and analgesics; systemic
2.3
8.4
74
324
I50.1
ICD-10 Finland
Left ventricular failure
2.1
8.4
87
410
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
8.4
660
5217
R03AC03
ATC
terbutaline; inhalant
1.3
8.4
518
3951
L02
ICPC
Back symptom/complaint
1.5
8.4
315
2196
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
90.2
8.4
9
*
D07AC01
ATC
betamethasone; topical
1.2
8.4
1217
10377
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.0
8.4
103
521
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
2.3
8.4
74
325
N05CD07
ATC
temazepam; oral
1.4
8.4
365
2621
M03BC51
ATC
orphenadrine, combinations; systemic
1.2
8.4
1091
9194
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
2.7
8.4
54
201
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
8.4
171
1031
LAE10
NOMESCO Finland
Unilateral oophorectomy
4.2
8.4
30
72
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
+∞
8.3
8
*
E85.0
ICD-10 Finland
Non-neuropathic heredofamilial amyloidosis
+∞
8.3
8
*
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
8.3
210
1340
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
5.0
8.3
25
50
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
8.3
117
625
YNB10
NOMESCO Finland
Collection of stem cells for transplant
8.5
8.3
17
20
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.0
8.3
45
151
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
8.3
1040
8725
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
8.3
441
3285
JEA00
NOMESCO Finland
Appendectomy
1.6
8.3
234
1532
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
3.2
8.3
41
129
H3600, E103
ICD-10 Finland
NA
3.2
8.3
41
129
LAD00
NOMESCO Finland
Partial excision of ovary
5.5
8.3
23
42
G04CA02
ATC
tamsulosin; oral
1.4
8.3
327
2306
H01CB03
ATC
lanreotide; parenteral
7.1
8.2
19
27
8070/3-C53.9
ICD-O-3
Squamous cell carcinoma, NOS, of cervix uteri
7.1
8.2
19
27
K90.0
ICD-10 Finland
Coeliac disease
1.9
8.2
110
575
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
8.2
215
1383
L20
ICPC
Joint symptom/complaint NOS
1.9
8.2
122
662
K30
ICD-10 Finland
Functional dyspepsia
1.4
8.2
376
2728
J01DA06
ATC
[U] cefuroxime; systemic
1.3
8.2
536
4124
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.8
8.2
132
740
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
8.2
582
4534
A01AB04
ATC
amphotericin B; local oral
1.7
8.2
166
999
8204
FHL
Salpingo-oophorectomy
2.6
8.2
56
214
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
8.2
194
1218
UJC01
NOMESCO Finland
Scopy of lower throat
3.4
8.2
38
114
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.3
8.2
533
4099
I47.2
ICD-10 Finland
Ventricular tachycardia
2.7
8.2
54
205
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.3
8.1
39
120
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
3.0
8.1
43
142
CD2S4
NOMESCO Finland
Photography of eye
5.4
8.1
23
43
E000001
ATC
NA
1.3
8.1
745
6016
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
8.1
125
689
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.0
8.1
103
531
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.8
8.1
140
802
A29
ICPC
General symptom/complaint other
1.4
8.1
355
2556
A12BA01
ATC
potassium chloride; oral
1.9
8.1
109
574
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.2
8.1
77
352
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.4
8.0
64
269
J31.0
ICD-10 Finland
Chronic rhinitis
1.5
8.0
267
1816
SPAT1336
SPAT
Request for examination
1.8
8.0
123
679
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
22.0
8.0
11
5
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.6
8.0
190
1191
H26.4
ICD-10 Finland
After-cataract
1.5
8.0
243
1622
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
8.0
645
5121
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.7
8.0
169
1030
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
8.0
47
166
G03HA01
ATC
cyproterone; systemic
4.6
8.0
26
57
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.4
8.0
326
2315
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
3.6
7.9
33
91
KBV00
NOMESCO Finland
Insertion of stent into ureter
4.7
7.9
25
53
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.7
7.9
32
86
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
1.9
7.9
102
530
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.0
7.9
99
505
SPAT1260
SPAT
Consultation of another employee
1.3
7.9
592
4648
H02AB02
ATC
dexamethasone; systemic
1.4
7.9
358
2594
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
6.6
7.9
19
29
E27.0
ICD-10 Finland
Other adrenocortical overactivity
13.0
7.9
13
10
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
13.0
7.9
13
10
K05.1
ICD-10 Finland
Chronic gingivitis
1.5
7.9
259
1757
P06
ICPC
Sleep disturbance
1.4
7.8
330
2355
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
2.5
7.8
56
223
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
7.8
443
3332
E04
ICD-10 Finland
Other nontoxic goitre
5.4
7.8
22
41
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.8
401
2970
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
8.4
7.8
16
19
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
8.4
7.8
16
19
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
7.8
83
400
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
7.8
252
1704
E000003
ATC
NA
1.7
7.7
151
898
R07.3
ICD-10 Finland
Other chest pain
1.5
7.7
285
1984
M01AH02
ATC
rofecoxib; oral
1.4
7.7
444
3350
2521A
ICD-9 Finland
Disorders of parathyroid gland, Hypoparathyroidism
45.0
7.7
9
*
CEC90
NOMESCO Finland
Total transposition of extraocular muscle or muscles
45.0
7.7
9
*
B02AA02
ATC
tranexamic acid; systemic
1.3
7.7
640
5095
R09
ICPC
Sinus symptom/complaint
1.4
7.7
303
2135
N80
ICD-10 Finland
Endometriosis
3.4
7.7
35
104
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
7.4
7.7
17
23
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
7.4
7.7
17
23
R25.1
ICD-10 Finland
Tremor, unspecified
2.0
7.6
87
431
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.8
7.6
129
736
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.3
7.6
69
309
R4120
NOMESCO Finland
Occupational therapy
1.6
7.6
196
1258
TPX15
NOMESCO Finland
Removal of vascular injection port
4.4
7.6
26
60
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.6
7.6
188
1194
E66.9
ICD-10 Finland
Obesity, unspecified
1.9
7.6
113
616
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
7.6
502
3868
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
7.6
375
2756
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
7.6
71
322
N04BC06
ATC
cabergoline; oral (dopamine agonists)
4.2
7.6
27
65
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
4.9
7.6
23
47
A60
ICPC
General and Unspecified, Result test/procedure
1.7
7.5
144
851
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.8
7.5
30
80
H05BX01
ATC
cinacalcet; oral
5.7
7.5
20
35
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
2.0
7.5
90
455
C10AB05
ATC
fenofibrate; oral
2.9
7.5
43
148
L95
ICPC
Osteoporosis
1.9
7.5
108
582
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.7
7.5
133
772
Z94.0
ICD-10 Finland
Kidney transplant status
3.5
7.5
33
96
L60.0
ICD-10 Finland
Ingrowing nail
1.7
7.5
136
792
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.4
7.4
294
2075
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.4
7.4
25
57
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
4.4
7.4
25
57
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
7.4
1240
10712
5AD01
NOMESCO Finland
NA
80.2
7.4
8
*
E83.59
ICD-10 Finland
Other disorders of calcium metabolism
80.2
7.4
8
*
LCW96
NOMESCO Finland
Other operation on uterus and uterine ligaments
80.2
7.4
8
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
80.2
7.4
8
*
J45
ICD-10 Finland
Asthma
1.4
7.4
346
2519
A46
ICD-10 Finland
Erysipelas
1.4
7.4
366
2692
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.5
7.4
212
1398
CEC00
NOMESCO Finland
Recession of extraocular muscle
4.5
7.4
24
53
B02.9
ICD-10 Finland
Zoster without complication
1.6
7.4
176
1110
D06
ICPC
Abdominal pain localized other
1.5
7.4
276
1925
B03XA02
ATC
darbepoetin alfa; parenteral
2.8
7.4
44
158
C01AA05
ATC
digoxin; systemic
1.6
7.3
161
991
D11
ICPC
Diarrhoea
1.4
7.3
381
2823
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
2.4
7.3
59
250
5BA08
NOMESCO Finland
NA
3.9
7.3
28
72
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
7.3
480
3695
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
7.3
67
302
M54.6
ICD-10 Finland
Pain in thoracic spine
1.5
7.3
238
1612
J37.0
ICD-10 Finland
Chronic laryngitis
1.9
7.3
105
567
I25.2
ICD-10 Finland
Old myocardial infarction
1.9
7.3
93
482
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.8
7.3
120
676
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.9
7.3
105
568
2754A
ICD-9 Finland
Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]
+∞
7.3
7
*
N08.4*E85.9
ICD-10 Finland
Glomerular disorders in amyloidosis
+∞
7.3
7
*
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
+∞
7.3
7
*
CA1BD
NOMESCO Finland
Extensive orbita CT
10.9
7.3
13
12
ZSB00
NOMESCO Finland
Procedure related to previous procedure classified in chapter B
10.9
7.3
13
12
J01CA08
ATC
pivmecillinam; oral
1.2
7.3
1825
16371
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
7.3
710
5771
T72
ICPC
Benign neoplasm thyroid
6.8
7.3
17
25
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.5
7.3
32
93
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.3
7.3
66
295
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
7.3
150
909
B82
ICPC
Anaemia other/unspecified
2.2
7.2
71
328
R05
ICPC
Cough
1.3
7.2
788
6493
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.9
7.2
42
147
M01AG01
ATC
mefenamic acid; oral
1.8
7.2
110
605
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.3
7.2
61
265
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
7.2
387
2883
E06.5
ICD-10 Finland
Other chronic thyroiditis
15.7
7.2
11
7
D35.1
ICD-10 Finland
Benign neoplasm: Parathyroid gland
5.4
7.2
20
37
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.2
828
6869
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
7.2
299
2129
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.2
7.2
71
331
LAC00
NOMESCO Finland
Excision of ovarian cyst
4.6
7.2
23
50
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.9
7.2
104
565
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
7.2
83
415
WX723
NOMESCO Finland
CPAP therapy
1.9
7.1
102
551
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.3
7.1
63
279
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
30.0
7.1
9
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
7.1
370
2745
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.9
7.1
39
133
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.5
7.1
246
1690
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.3
7.1
65
291
N06AB04
ATC
citalopram; systemic
1.3
7.1
769
6329
M01AE02
ATC
naproxen; oral, rectal
1.2
7.1
2277
20856
WX610
NOMESCO Finland
Patient controlled analgesia
3.4
7.1
32
95
2AB04
NOMESCO Finland
NA
5.0
7.1
21
42
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.5
7.1
228
1542
R03BA08
ATC
ciclesonide; inhalant
1.4
7.1
291
2071
I95.1
ICD-10 Finland
Orthostatic hypotension
2.1
7.1
73
348
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
3.5
7.1
31
90
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.0
7.1
87
446
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.7
7.0
46
174
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.0
7.0
84
424
SPAT1281
SPAT
Other administrative function
1.5
7.0
252
1743
M05BA04
ATC
alendronic acid; oral
1.5
7.0
269
1887
R05FB02
ATC
cough suppressants and expectorants
1.2
7.0
1389
12189
JFB46
NOMESCO Finland
Resection of sigmoid colon
2.7
7.0
43
158
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
7.0
416
3158
A02BX02
ATC
sucralfate; oral
1.7
7.0
125
728
N97.1
ICD-10 Finland
Female infertility of tubal origin
2.7
7.0
45
168
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.8
7.0
104
569
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.6
6.9
162
1017
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
6.3
6.9
17
27
L03
ICPC
Low back symptom/complaint
1.2
6.9
852
7118
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.8
6.9
41
147
C56.92
ICD-10 Finland
Malignant ovarian tumor, sex chord stroma derived
7.5
6.9
15
20
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
13.8
6.9
11
8
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
6.9
95
505
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
6.9
401
3031
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.3
6.8
58
252
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.8
6.8
109
612
L12
ICPC
Hand/finger symptom/complaint
1.3
6.8
487
3797
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.8
255
1778
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
6.8
99
538
J38.3
ICD-10 Finland
Other diseases of vocal cords
2.8
6.8
40
142
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.8
1879
16970
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
6.7
6.8
16
24
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.8
284
2025
T73
ICPC
Neoplasm endocrine other/unspecified
10.9
6.8
12
11
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.2
6.8
33
104
A03FA02
ATC
cisapride; oral, rectal
1.5
6.8
239
1650
A99
ICPC
Disease/condition unspecnature/site
1.5
6.8
236
1624
ZYC06
NOMESCO Finland
Real-time text-based remote transaction
9.3
6.8
13
14
JAL97
NOMESCO Finland
Other laparoscopic excision of lesion of peritoneum
6.1
6.8
17
28
JGB04
NOMESCO Finland
Laparoscopic partial proctectomy with partial excision of mesorectum
6.1
6.8
17
28
8290/3-C73.9
ICD-O-3
Oxyphilic adenocarcinoma of thyroid gland
40.1
6.8
8
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
3.2
6.8
32
99
E23
ICD-10 Finland
Hypofunction and other disorders of pituitary gland
16.7
6.7
10
6
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.4
6.7
275
1952
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
6.7
526
4151
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
6.7
126
744
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
6.7
655
5325
M01AE51
ATC
ibuprofen, combinations; systemic
2.3
6.7
57
249
S22
ICPC
Nail symptom/complaint
1.6
6.7
178
1153
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.5
6.7
29
84
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.7
6.7
41
151
J01DC02
ATC
cefuroxime; systemic
1.5
6.7
201
1343
N01
ICPC
Headache
1.4
6.6
343
2545
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.1
6.6
72
351
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.5
6.6
50
204
JFB00
NOMESCO Finland
Partial resection of small intestine
2.6
6.6
45
176
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
6.6
120
703
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
12.2
6.6
11
9
2429X
ICD-9 Finland
Thyrotoxicosis with or without goitre, Thyrotoxicosis without mention of goitre or other cause
12.2
6.6
11
9
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
12.2
6.6
11
9
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
2.3
6.6
54
233
A10AE06
ATC
insulin degludec; parenteral
1.9
6.6
83
431
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
6.6
270
1923
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.3
6.6
57
253
CEW99
NOMESCO Finland
Other operation on extraocular muscle
8.7
6.5
13
15
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
8.7
6.5
13
15
1CX01
NOMESCO Finland
NA
8.7
6.5
13
15
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.7
6.5
136
825
UJK02
NOMESCO Finland
ERCP
2.1
6.5
69
333
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
4.8
6.5
20
42
C90.0
ICD-10 Finland
Multiple myeloma
3.2
6.5
32
102
K92.1
ICD-10 Finland
Melaena
1.8
6.5
110
631
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
6.5
810
6773
R31
ICD-10 Finland
Unspecified haematuria
1.5
6.5
206
1393
Z93.2
ICD-10 Finland
Ileostomy status
5.3
6.4
18
34
R96
ICPC
Asthma
1.4
6.4
285
2057
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.2
6.4
58
260
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
5.7
6.4
17
30
XF602
NOMESCO Finland
Bloodpressure monitoring
3.1
6.4
32
103
M02AA07
ATC
piroxicam; topical
1.2
6.4
1311
11516
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.4
35
120
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
6.4
207
1404
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.7
6.4
114
660
N17
ICPC
Vertigo/dizziness
1.4
6.4
337
2508
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
6.4
79
404
355
Kela drug reimbursment
Dienogest
7.4
6.4
14
19
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
14.3
6.4
10
7
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
14.3
6.4
10
7
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.9
6.4
83
433
C07AG02
ATC
carvedilol; oral
1.6
6.4
138
849
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.7
6.4
121
718
N02AC04
ATC
dextropropoxyphene; oral
1.8
6.4
99
551
ZXB10
NOMESCO Finland
Medial
3.6
6.4
26
72
ED1AA
NOMESCO Finland
Mandipular X-ray examination
3.6
6.4
26
72
R01AD12
ATC
fluticasone furoate; nasal
1.2
6.4
1166
10138
H53.4
ICD-10 Finland
Visual field defects
2.2
6.4
60
275
R03AC12
ATC
salmeterol; inhalant
1.6
6.3
136
834
N83.0
ICD-10 Finland
Follicular cyst of ovary
2.2
6.3
61
284
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
2.7
6.3
41
153
6173A
ICD-9 Finland
Endometriosis of pelvic peritoneum[ENDOMETRIOSIS SEROSAE PELVIS]
2.7
6.3
41
153
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.7
6.3
122
725
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.3
2073
18951
KAC10
NOMESCO Finland
Total nephrectomy with capsule
3.4
6.3
28
83
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2.3
6.3
52
225
S97
ICPC
Chronic ulcer skin
1.7
6.3
127
766
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
5.9
6.3
16
27
G03GA01
ATC
chorionic gonadotrophin; parenteral
1.6
6.3
158
1010
H03AA02
ATC
liothyronine sodium; systemic
9.2
6.3
12
13
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.0
6.3
76
387
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
4.0
6.3
23
58
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
18.0
6.3
9
5
WX872
NOMESCO Finland
Intensive care
1.8
6.3
102
578
25219
ICD-8 Finland
Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD
+∞
6.2
6
*
E8901, E050
ICD-10 Finland
NA
+∞
6.2
6
*
E87.2
ICD-10 Finland
Acidosis
+∞
6.2
6
*
E83.58
ICD-10 Finland
Idiopathic hypercalciuria
+∞
6.2
6
*
2768A
ICD-9 Finland
Disorders of fluid, electrolyte and acid-base balance, Hypopotassaemia[HYPOKALAEMIA]
+∞
6.2
6
*
EB1WA
NOMESCO Finland
NA
3.3
6.2
29
89
M01AH05
ATC
etoricoxib; oral
1.2
6.2
2348
21691
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.0
6.2
78
403
C74.1
ICD-10 Finland
Malignant neoplasm: Medulla of adrenal gland
26.7
6.2
8
*
2542
FHL
Transasal hypophysectomy
26.7
6.2
8
*
E13.7
ICD-10 Finland
Other specified diabetes mellitus, with multiple complications
26.7
6.2
8
*
M01AG02
ATC
tolfenamic acid; oral, rectal
1.3
6.2
637
5207
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
7.0
6.2
14
20
J01FA15
ATC
telithromycin; oral
1.4
6.2
357
2694
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.2
1532
13680
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.8
6.2
105
603
A10BK03
ATC
empagliflozin; oral
1.6
6.2
165
1073
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.6
6.2
42
165
-34
ICPC
Blood test
1.8
6.2
99
557
Y84.9
ICD-10 Finland
Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
6.2
24
64
WF002
NOMESCO Finland
Radical radiotherapy
1.7
6.2
112
657
R07.0
ICD-10 Finland
Pain in throat
1.5
6.1
205
1403
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.4
6.1
322
2397
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
1.9
6.1
77
399
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
6.1
104
596
-31
ICPC
Medical examin/health eval partial
1.5
6.1
213
1468
R05
ICD-10 Finland
Cough
1.3
6.1
645
5296
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
6.1
316
2349
C07AB03
ATC
atenolol; systemic
1.6
6.1
148
942
M48.0
ICD-10 Finland
Spinal stenosis
1.4
6.1
321
2390
T28
ICPC
Limited function/disability (T)
2.9
6.0
35
123
3AC01
NOMESCO Finland
NA
2.9
6.0
35
123
212
Kela drug reimbursment
Gout
2.7
6.0
38
143
FM2CE
NOMESCO Finland
NA
8.6
6.0
12
14
R03AK08
ATC
formoterol and beclometasone; inhalant
1.7
6.0
123
745
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
4.9
6.0
18
37
ZX112
NOMESCO Finland
Subcutaneous
2.0
6.0
70
352
6170A
ICD-9 Finland
Endometriosis of uterus
2.5
6.0
43
171
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.7
6.0
126
767
WX780
NOMESCO Finland
Remote monitoring CPAP
1.7
6.0
105
606
A04AA02
ATC
granisetron; systemic, transdermal
1.5
6.0
193
1308
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3607
19239
3.82
307.65
12.2
5.2
mmol/l
1.2
1.2
53.13
3067
16137
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
796
198
47.24
307.65
7.4
5.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
2626
11277
3.67
307.65
8.4
3.3
ph
7.4
7.4
0.24
534
2158
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
836
371
26.63
307.65
7.4
3.7
u/ml
48.9
99.6
1.05
306
99
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3290
17324
3.42
307.65
10.5
4.7
mmol/l
1.2
1.2
54.78
3121
15576
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1032
1093
11.52
307.65
3.0
1.8
iu/l
11.5
4.0
0.81
608
391
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1244
2583
6.01
307.65
4.3
3.1
ng/l
55.5
79.4
19.89
1095
2217
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2104
2834
11.75
307.65
6.7
3.0
pmol/l
4.5
4.5
0.70
1969
2530
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1212
3999
3.64
303.46
7.4
4.5
mmol/l
1.1
1.0
10.17
1128
3691
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4829
35331
5.79
302.29
12.1
4.1
pmol/l
16.3
14.6
318.85
4670
32464
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1423
5444
3.22
278.50
5.1
3.0
mmol/l
0.8
0.8
14.55
1337
5068
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3021
18225
2.56
234.20
3.1
2.2
nmol/l
76.6
77.9
1.68
2841
16539
(3015377) Calcium [Moles/volume] in Serum or Plasma
2454
13857
2.45
213.45
4.1
3.2
mmol/l
2.3
2.4
40.15
2242
12161
(3024561) Albumin [Mass/volume] in Serum or Plasma
2663
16586
2.23
172.41
6.4
4.1
g/l
36.0
36.1
0.39
2499
15356
(3036481) Cortisol [Moles/volume] in Serum or Plasma
910
3603
2.85
158.98
2.8
2.1
nmol/l
368.0
372.4
0.15
854
3321
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4909
40967
4.24
155.61
13.7
4.7
mu/l
2.0
2.0
0.00
4732
37914
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4192
32242
2.51
153.63
10.6
6.8
u/l
75.9
75.9
0.02
4045
30265
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
430
1083
4.24
153.54
1.4
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
153
140
11.23
144.30
1.9
1.5
pmol/l
16.4
15.0
1.08
137
119
(3013650) Neutrophils [#/volume] in Blood by Automated count
3385
24307
2.11
139.05
12.2
8.7
e9/l
3.9
3.9
0.23
3024
21290
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
321
703
4.80
136.60
2.9
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3197
22778
2.04
130.13
6.5
3.8
mmol/l
6.6
6.5
1.33
3040
20980
(3044640) Blood type and Crossmatch panel - Blood
2085
12938
2.02
123.78
3.1
2.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
813
3587
2.50
111.48
1.3
1.2
iu/ml
184.5
157.0
0.88
359
1417
(3010838) Calcium [Moles/time] in 24 hour Urine
141
178
8.11
104.41
2.0
1.7
mmol/24h
6.1
6.3
0.04
13
14
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2897
20897
1.87
102.74
8.3
5.6
umol/l
9.9
10.4
2.77
2769
19740
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2769
19723
1.86
101.92
4.9
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2884
20848
1.85
100.79
7.3
5.7
e9/l
0.6
0.6
0.28
2551
18116
(3013115) Eosinophils [#/volume] in Blood
2967
21665
1.85
100.09
7.7
5.9
e9/l
0.2
0.2
0.04
2648
19178
(3006315) Basophils [#/volume] in Blood
2884
20928
1.84
98.70
7.3
5.7
e9/l
0.0
0.0
0.49
2550
18158
(3032080) INR in Blood by Coagulation assay
2142
14194
1.86
98.21
10.0
6.9
inr
1.2
1.2
0.68
701
4249
(3019198) Lymphocytes [#/volume] in Blood
2944
21519
1.84
98.20
7.3
5.7
e9/l
1.9
1.9
0.61
2648
19104
(42870588) Differential panel, method unspecified - Blood
2064
13525
1.87
98.01
7.5
5.9
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
716
3169
2.46
96.63
6.7
3.0
mmol/l
1.2
1.2
26.64
651
2724
(3022096) Basophils/100 leukocytes in Blood
2641
18801
1.82
94.76
7.6
5.9
%
0.7
0.7
0.96
2501
17472
(3021589) Normoblasts [#/volume] in Blood
2610
18649
1.80
91.23
12.7
8.4
e9/l
0.0
0.0
0.29
2153
15233
(3006504) Eosinophils/100 leukocytes in Blood
2694
19445
1.80
90.85
7.5
5.8
%
2.8
2.8
0.17
2543
18047
(3019069) Monocytes/100 leukocytes in Blood
2705
19556
1.79
90.64
7.8
6.1
%
8.5
8.3
1.50
2567
18281
(3002030) Lymphocytes/100 leukocytes in Blood
2768
20175
1.79
89.96
7.6
5.9
%
28.3
29.1
3.18
2625
18755
(3033658) Prothrombin time (PT) actual/Normal
1596
9867
1.89
89.07
5.0
3.3
%
94.5
94.7
0.10
1562
9607
(3044889) 12 lead EKG panel
3643
29004
1.84
86.09
4.2
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
604
2614
2.48
85.02
4.8
3.2
mmol/l
2.1
2.0
0.40
498
2125
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2683
19591
1.76
84.64
3.6
2.7
ug/l
118.6
98.9
3.85
2500
18290
(3012544) pH of Venous blood
621
2732
2.44
84.32
4.8
3.2
ph
7.4
7.4
—
7
14
(3011985) Renin [Units/volume] in Plasma
190
404
4.84
83.45
2.7
1.3
mu/l
51.5
49.9
0.06
171
361
(3026782) Osmolality of Urine
1222
7048
1.96
83.24
3.2
2.4
mosm/kgh2o
527.2
534.3
0.53
1064
5939
(3018010) Neutrophils/100 leukocytes in Blood
2709
19925
1.75
82.47
7.4
5.6
%
56.8
56.6
0.51
2569
18595
(3013707) Erythrocyte sedimentation rate by Westergren method
3927
32222
1.88
81.57
4.7
3.9
mm/h
12.4
11.3
5.19
3712
29941
(3021447) Carbon dioxide [Partial pressure] in Venous blood
599
2637
2.44
81.06
4.8
3.2
kpa
5.9
5.8
1.47
580
2555
(3019550) Sodium [Moles/volume] in Serum or Plasma
4933
44220
3.04
80.52
21.8
11.9
mmol/l
139.7
139.8
1.19
4851
43036
(3014576) Chloride [Moles/volume] in Serum or Plasma
791
3933
2.19
80.37
9.0
6.1
mmol/l
104.4
104.6
0.72
775
3860
(3002385) Erythrocyte distribution width [Ratio]
4314
36578
2.03
80.35
24.6
13.7
%
13.7
13.6
2.99
4244
35746
(3020779) Urea [Moles/volume] in Serum or Plasma
566
2445
2.47
79.77
11.7
6.0
mmol/l
8.8
8.5
0.53
543
2337
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1231
7215
1.92
79.44
3.5
2.8
mmol/l
2.4
2.4
12.55
1085
6338
(3023103) Potassium [Moles/volume] in Serum or Plasma
4940
44383
3.05
78.97
22.4
12.0
mmol/l
3.9
3.9
10.68
4850
43087
(3022948) Iron [Moles/volume] in Serum or Plasma
1010
5541
2.02
78.94
2.9
2.1
umol/l
13.1
13.7
1.65
939
5128
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
876
4566
2.10
78.69
3.0
2.2
%
22.5
23.1
0.54
744
3914
(40758558) Short blood count panel - Blood
1633
10538
1.80
77.14
9.8
6.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
931
5000
2.05
77.01
2.9
2.1
g/l
2.4
2.4
0.68
872
4621
(3018095) Leukocytes [#/volume] in Urine
1999
13720
1.74
75.97
4.5
3.2
e6/l
78.7
99.6
0.87
1437
9334
(3002582) Erythrocytes [#/volume] in Urine
1702
11251
1.76
73.23
3.8
2.7
e6/l
28.7
83.7
3.37
1335
8467
(3003396) Base excess in Arterial blood by calculation
708
3497
2.19
72.66
7.5
6.6
mmol/l
1.0
1.1
0.24
573
2709
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1500
9586
1.79
72.33
2.4
2.1
mg/l
2.9
2.9
0.19
1300
8233
(3027801) Oxygen [Partial pressure] in Arterial blood
706
3509
2.17
71.23
7.5
6.6
kpa
13.0
12.9
0.18
677
3346
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
706
3510
2.17
71.18
7.5
6.6
kpa
5.1
5.1
0.81
677
3350
(3030467) Casts [#/volume] in Urine by Automated count
1592
10403
1.76
70.83
3.7
2.7
e6/l
0.3
0.4
1.91
1224
7741
(3023368) Bacteria identified in Blood by Culture
1419
9021
1.79
69.10
6.0
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
717
3631
2.13
68.80
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
718
3652
2.12
68.07
2.0
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
632
3062
2.21
67.80
8.0
7.0
%
96.0
96.0
0.04
609
2952
(3002173) Hemoglobin [Mass/volume] in Arterial blood
601
2883
2.23
65.98
8.2
7.2
g/l
119.9
121.1
0.72
576
2775
(3000991) Gas panel - Venous blood
535
2445
2.32
65.94
9.2
7.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
180
447
4.13
64.91
2.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1494
9804
1.73
64.29
2.8
2.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
137
280
5.00
63.02
3.5
2.0
nmol/l
19.7
19.5
0.08
128
267
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
696
3616
2.07
62.00
8.4
4.2
u/l
233.4
239.9
0.58
662
3434
(3017446) Testosterone [Moles/volume] in Serum or Plasma
386
1564
2.59
61.79
3.8
2.0
nmol/l
11.6
12.0
0.32
352
1393
(36304419) Bacteria [Presence] in Urine
1538
10278
1.70
61.40
3.7
2.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1911
13522
1.65
61.25
3.6
3.0
u/l
30.5
31.7
0.42
1829
12829
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
385
1566
2.57
61.13
8.8
9.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
948
5505
1.88
61.04
2.1
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1624
11057
1.68
60.20
2.3
1.9
u/l
174.5
186.1
0.24
1539
10378
(3018677) aPTT in Platelet poor plasma by Coagulation assay
885
5051
1.91
60.02
3.2
2.0
s
29.9
29.4
1.38
865
4889
(3000850) Epithelial cells [#/volume] in Urine
1243
7921
1.75
58.48
2.9
2.3
e6/l
5.8
6.9
2.10
1096
6863
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1388
9137
1.71
57.98
3.5
2.6
ng/l
1233.5
998.2
1.00
1201
7662
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2152
15836
1.61
57.95
2.1
1.8
pmol/l
96.5
98.6
1.23
1158
7937
(3027945) Reticulocytes/100 erythrocytes in Blood
668
3521
2.03
56.90
4.6
2.5
%
1.8
1.7
0.93
603
3147
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
520
2496
2.20
56.63
1.9
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4800
43619
2.22
55.57
20.1
11.3
mg/l
20.4
21.2
1.01
4034
33620
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1769
12538
1.62
54.81
2.9
2.3
u/l
56.8
58.0
0.33
1645
11547
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1072
6710
1.75
53.04
4.1
3.0
ng/l
214.0
385.5
1.40
767
4582
(3004119) Hemoglobin [Mass/volume] in Venous blood
398
1764
2.36
52.28
4.3
2.6
g/l
129.2
129.8
0.21
383
1720
(3007164) IgA [Mass/volume] in Serum or Plasma
1313
8745
1.67
51.47
1.6
1.4
g/l
2.2
2.3
0.76
825
5389
(3026008) Bacteria identified in Urine by Culture
1737
12404
1.60
51.38
3.3
2.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
776
4458
1.87
50.88
6.5
2.5
umol/l
6.2
7.1
0.94
685
3802
(3037467) Urinalysis macro (dipstick) panel - Urine
3487
29214
1.58
50.41
5.1
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
528
2678
2.08
49.63
7.8
6.0
mmol/l
1.2
1.3
0.61
513
2594
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1490
10342
1.62
49.16
1.4
1.3
u/ml
1.6
1.4
0.34
432
2923
(3012565) Volume of 24 hour Urine
89
155
5.82
48.83
2.5
2.2
ml
1918.6
1924.6
0.02
78
142
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
925
5670
1.77
48.79
3.5
2.5
e6/l
3.3
3.6
0.37
470
2942
(3031040) Bacteria [#/volume] in Urine by Automated count
3353
27977
1.55
48.11
5.2
4.1
e6/l
528.1
2220.1
3.11
56
312
(3010375) cycloSPORINE [Mass/volume] in Blood
83
138
6.10
47.75
39.7
23.5
ug/l
139.0
118.3
1.79
77
116
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
991
6258
1.72
46.84
3.2
2.4
e6/l
1.0
1.3
1.19
528
3509
(3027273) Bicarbonate [Moles/volume] in Venous blood
321
1364
2.44
46.23
4.1
2.6
mmol/l
26.1
25.5
2.17
308
1323
(3035350) Ketones [Presence] in Urine by Test strip
2602
20716
1.51
45.22
4.2
3.4
estimate
0.0
0.0
1.08
546
3821
(3005719) IgG [Mass/volume] in Serum or Plasma
559
2997
1.97
44.83
3.2
2.8
g/l
10.0
10.6
3.19
515
2764
(3009508) Creatinine [Moles/volume] in Urine
1547
11038
1.57
44.53
3.3
3.0
mmol/l
6.8
7.3
4.72
1347
9287
(3042936) Bacteria identified in Isolate by Culture
849
5202
1.75
44.46
2.2
1.9
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
141
387
3.72
44.22
1.4
1.3
pmol/l
322.1
288.4
0.47
121
297
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
44
37
11.98
43.66
3.8
1.8
pmol/l
56.5
41.3
0.82
37
30
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
157
467
3.43
43.62
1.8
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2603
20872
1.49
42.73
5.7
4.6
estimate
0.0
0.0
0.80
558
3882
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1860
13925
1.52
42.58
3.8
2.9
ng/l
201.7
80.1
0.32
1149
8179
(3020682) Albumin/Creatinine [Ratio] in Urine
1470
10460
1.56
42.42
4.2
3.7
mg/mmol
12.6
6.9
2.44
913
6165
(3012516) Albumin [Mass/volume] in Urine
1413
9977
1.57
42.13
3.5
3.0
mg/l
747.4
396.1
1.22
870
5817
(3009261) Glucose [Presence] in Urine by Test strip
2620
21074
1.49
42.10
4.2
3.5
estimate
0.0
0.0
0.34
545
3838
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
165
518
3.26
42.07
1.8
1.2
nmol/l
0.4
0.4
0.04
11
23
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1333
9309
1.58
41.61
2.4
1.7
mg/l
1.2
1.0
0.45
1030
7032
(4035726)
645
3714
1.84
41.42
1.5
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2365
18706
1.48
40.90
2.3
2.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
487
2572
1.99
40.63
3.6
2.5
e9/l
71.8
69.4
0.69
360
1906
(3026493) Urate [Moles/volume] in Serum or Plasma
1389
9876
1.55
39.74
3.2
2.2
umol/l
4205.2
3815.5
0.14
1231
8583
(3021960) Folate [Moles/volume] in Serum or Plasma
1233
8534
1.58
39.70
1.6
1.5
nmol/l
21.0
21.1
0.06
1096
7297
(3036603) Volume of Urine
94
207
4.61
39.61
1.6
1.4
ml
1908.8
1888.1
0.04
19
40
(3024354) Oxygen [Partial pressure] in Venous blood
434
2224
2.04
39.37
3.9
2.7
kpa
4.5
4.6
0.31
419
2153
(40761511) CBC panel - Blood by Automated count
4921
46006
2.18
39.28
18.4
10.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
191
679
2.88
39.28
10.3
4.5
iu/ml
673.9
342.2
0.69
31
68
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
304
1355
2.32
39.24
5.3
3.6
mmol/l
24.5
24.3
0.30
277
1206
(40760892) CBC W Ordered Manual Differential panel - Blood
1380
9837
1.55
38.88
5.1
4.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
390
1934
2.10
38.64
7.3
6.6
mmol/l
24.8
24.7
0.34
362
1790
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
647
3809
1.80
38.47
3.9
2.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
282
1232
2.36
38.10
5.0
4.9
%
1.7
1.6
0.47
266
1152
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
89
195
4.63
37.74
2.4
2.7
%
37.0
43.2
0.77
18
67
(3020630) Protein [Mass/volume] in Serum or Plasma
493
2697
1.91
36.97
3.3
2.4
g/l
66.3
66.9
1.13
462
2465
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
139
426
3.32
36.87
4.3
3.1
nmol/l
4.0
17.1
0.51
134
417
(3007930) Methemoglobin/Hemoglobin.total in Blood
279
1233
2.33
36.71
5.0
4.9
%
0.9
0.9
0.16
263
1150
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4493
41013
1.68
36.16
18.4
10.2
ml/min/173m2
83.6
84.2
1.02
3948
33610
(3019060) Gas panel - Arterial blood
393
2004
2.04
36.07
5.1
4.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
236
980
2.47
35.67
5.1
5.7
mmol/l
1.2
1.2
0.19
206
852
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
326
1560
2.16
35.38
9.6
8.4
mmol/l
24.5
24.3
0.43
306
1453
(3004588) Protein electrophoresis panel - Serum or Plasma
419
2201
1.98
35.36
3.2
2.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
978
6600
1.59
34.45
1.8
1.7
nmol/l
1204.9
1180.2
0.35
781
5039
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
282
1290
2.25
34.20
2.1
1.8
g/l
1.5
1.5
0.09
250
1103
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
580
3418
1.78
34.16
2.3
2.1
g/l
0.2
0.2
1.39
551
3223
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4299
38974
1.58
33.78
6.2
4.8
mmol/mol
39.7
38.5
15.08
4066
36165
(3028026) IgM [Mass/volume] in Serum or Plasma
424
2283
1.93
33.24
1.9
1.9
g/l
1.2
1.4
0.79
396
2101
(3007853) Bacteria identified in Skin by Aerobe culture
725
4598
1.67
32.67
1.9
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
215
899
2.45
32.01
1.4
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
176
672
2.68
31.63
5.9
6.9
mmol/l
11.3
11.0
0.51
160
597
(3018572) Chloride [Moles/volume] in Blood
176
673
2.67
31.54
5.9
6.9
mmol/l
105.6
105.6
0.03
160
598
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4937
46656
2.04
31.14
14.6
9.2
u/l
25.3
25.0
0.77
4840
45020
(21494815) CD4 cells/100 lymphocytes in Specimen
107
310
3.50
31.03
2.6
2.2
%
35.2
44.1
0.98
12
42
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1456
10927
1.46
30.57
1.8
1.6
mmol/l
1.4
1.3
3.11
1257
9184
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
95
258
3.73
30.34
2.8
2.8
e6/l
665.4
758.2
0.44
23
114
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
40
49
8.22
30.34
1.2
1.2
pmol/l
2.1
6.8
—
5
6
(3002256) Pathology report gross observation
854
5739
1.58
30.24
1.3
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
144
509
2.88
29.97
3.9
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
109
327
3.38
29.96
1.3
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
74
169
4.43
29.86
1.8
1.5
nmol/l
4.3
6.1
0.24
62
128
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
448
2545
1.83
29.65
3.8
2.6
ng/l
182.0
154.2
0.56
406
2300
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
205
871
2.41
29.48
4.8
3.1
ratio
1.4
1.5
0.24
20
80
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
210
903
2.38
29.40
4.8
3.2
mg/l
29.8
43.1
1.10
169
733
(3034860) Kappa light chains.free [Mass/volume] in Serum
210
905
2.38
29.26
4.8
3.2
mg/l
44.3
53.9
0.51
168
731
(3037522) Nuclear Ab [Titer] in Serum
911
6267
1.55
28.99
1.4
1.4
titre
495.7
581.1
0.72
178
1363
(1616796) Gas panel - Central venous blood
169
663
2.60
28.79
3.8
3.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
186
767
2.48
28.55
1.5
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
248
1161
2.19
28.41
2.0
1.3
u/l
14.5
12.9
0.74
201
965
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
591
3684
1.68
28.21
2.7
2.2
u/l
45.3
51.8
0.18
523
3137
(3003181) Sodium [Moles/volume] in Urine
111
353
3.19
27.79
1.5
1.3
mmol/l
60.8
68.3
1.09
97
273
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
194
827
2.40
27.70
4.0
3.3
mg/l
1.4
1.4
0.49
182
764
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
126
434
2.95
27.51
1.9
1.5
—
—
—
0
0
(3010421) pH of Blood
198
861
2.35
27.04
4.0
3.0
ph
7.4
7.4
0.14
170
709
(3008295) Osmolality of Serum or Plasma
94
275
3.46
26.90
1.7
1.6
mosm/kgh2o
281.3
284.4
0.69
73
207
(40760888) Immunoglobulin light chains.free panel - Serum
166
669
2.53
26.77
4.5
3.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
174
718
2.47
26.69
4.1
3.2
mmol/l
2.7
2.6
0.30
129
477
(3024932) HLA-DR beta [Type]
52
97
5.40
26.61
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4519
41959
1.57
26.46
4.8
4.0
mmol/l
5.9
5.7
8.44
4244
38540
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
172
713
2.46
26.13
1.6
1.3
u/ml
111.5
114.6
0.13
32
165
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
191
831
2.35
26.06
2.2
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
52
99
5.30
26.02
1.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
171
711
2.45
25.81
1.8
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
150
586
2.61
25.80
2.2
1.7
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
318
1702
1.92
25.28
1.9
2.0
u/l
38.4
40.4
0.99
285
1557
(3008536) Aspergillus sp Ab [Presence] in Serum
42
67
6.31
25.23
4.7
1.9
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
331
1797
1.90
25.21
1.1
1.1
u/ml
1.3
2.2
—
5
25
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
108
359
3.05
25.12
2.0
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
153
612
2.55
25.08
2.5
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
89
264
3.41
24.95
2.8
3.5
mu/l
17.9
26.4
1.88
84
252
(3052851) Hemolysis interference index of Serum or Plasma
228
1092
2.14
24.66
3.9
2.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
608
3944
1.61
24.63
3.7
4.0
ug/l
84.9
20.2
0.59
472
3077
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
186
820
2.32
24.63
2.3
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
260
1314
2.03
24.37
1.6
1.8
g/l
0.2
0.2
1.62
242
1247
(37021550) Renin [Units/volume] in Plasma --upright
41
67
6.16
24.06
1.6
1.3
mu/l
88.7
45.3
0.68
33
55
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
237
1166
2.08
23.90
2.7
2.1
%
94.4
94.3
0.04
221
1076
(3021387) Prolactin [Units/volume] in Serum or Plasma
311
1684
1.90
23.86
2.3
1.6
mu/l
320.5
297.6
0.56
286
1510
(3009445) Proteinase 3 Ab [Units/volume] in Serum
288
1529
1.94
23.45
1.7
1.5
u/ml
11.9
14.4
—
7
35
(3000570) Elastase.pancreatic [Mass/mass] in Stool
227
1110
2.09
23.27
1.5
1.4
ug/g
288.4
294.5
0.16
134
622
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
158
670
2.40
22.87
2.1
1.6
nmol/l
44.6
43.0
0.26
153
653
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
219
1064
2.10
22.84
3.7
2.5
g/l
3.5
3.6
0.79
212
1005
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
171
753
2.31
22.73
1.3
1.2
u/ml
305.6
268.2
0.86
115
474
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
192
891
2.20
22.51
4.6
3.0
u/ml
0.3
0.4
1.22
111
494
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
258
1340
1.97
22.40
3.7
2.3
%
0.6
0.7
0.54
247
1274
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
178
804
2.26
22.29
1.3
1.2
—
—
—
0
0
(3036489) Thrombin time
265
1394
1.95
22.17
2.4
1.9
s
21.4
21.0
0.57
234
1181
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
260
1359
1.96
22.16
1.6
1.8
g/l
1.2
1.2
1.27
241
1293
(3015235) Bicarbonate [Moles/volume] in Capillary blood
162
705
2.34
22.13
3.3
2.6
mmol/l
25.2
25.1
0.19
144
613
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
150
631
2.42
22.11
1.3
1.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
76
223
3.44
21.71
1.6
1.3
umol/l
4.3
4.8
0.42
70
206
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
489
3104
1.63
21.53
3.4
3.3
u/ml
37.1
50.7
0.87
473
2998
(3011397) Hemoglobin [Presence] in Urine by Test strip
1251
9649
1.39
21.13
3.9
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
813
5801
1.48
21.11
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1448
11442
1.37
21.05
3.9
3.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
215
1075
2.04
20.78
3.1
2.4
%
188.7
179.3
0.77
206
1024
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
116
446
2.64
20.67
2.3
1.7
pmol/l
178.5
198.4
0.86
107
417
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1115
8468
1.40
20.56
1.7
1.6
pmol/l
39957928.5
35071003.0
0.11
941
7157
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1956
16236
1.33
20.30
4.4
3.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
152
671
2.30
20.12
2.9
2.1
%
16.4
16.5
0.05
79
327
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
183
872
2.14
20.10
3.2
2.1
g/l
0.0
0.0
0.00
175
815
(3016650) Hepatitis A virus Ab [Presence] in Serum
150
661
2.31
19.94
1.3
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
61
164
3.75
19.87
1.6
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
61
164
3.75
19.87
1.6
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
184
883
2.12
19.84
3.2
2.1
g/l
0.0
0.0
0.50
175
817
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
105
393
2.71
19.74
9.0
6.2
mg/l
11.4
11.1
0.28
96
361
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
235
1237
1.94
19.64
3.1
3.5
u/ml
313.9
1417.0
0.70
208
1045
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
223
1153
1.98
19.63
3.5
2.2
g/l
9.8
10.4
1.09
195
980
(40760409) HLA-A [Type] by High resolution
20
17
11.81
19.57
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
20
17
11.81
19.57
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
20
17
11.81
19.57
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
216
1108
1.99
19.45
1.9
2.0
mg/l
10.5
10.9
0.24
204
1033
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3277
29307
1.32
19.44
3.4
2.8
u/l
46.4
40.4
2.83
3094
27504
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
35
61
5.77
19.28
1.6
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
1245
1.93
19.27
3.4
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
235
1246
1.93
19.22
3.4
2.1
g/l
7.4
7.3
0.18
190
953
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
107
412
2.63
19.04
1.3
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
5077
49168
2.12
18.99
30.3
16.9
pg
30.1
30.2
3.75
5032
48502
(3024731) MCV [Entitic volume]
5077
49170
2.12
18.95
30.3
16.9
fl
90.6
90.8
2.19
5032
48505
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
234
1245
1.92
18.95
3.4
2.1
g/l
3.9
3.7
0.42
185
901
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
225
1182
1.94
18.92
3.3
2.2
g/l
3.0
3.1
0.39
187
927
(3010813) Leukocytes [#/volume] in Blood
5078
49186
2.12
18.90
30.5
17.0
e9/l
6.6
6.6
1.06
4982
47858
(3026361) Erythrocytes [#/volume] in Blood
5077
49178
2.11
18.81
30.4
16.9
e12/l
4.5
4.5
0.23
4984
47868
(3028626) Oxygen [Partial pressure] in Capillary blood
142
627
2.30
18.81
3.2
2.9
kpa
8.4
8.4
0.05
135
580
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
191
949
2.05
18.80
3.2
2.1
g/l
0.0
0.0
0.22
182
880
(3007461) Platelets [#/volume] in Blood
5073
49135
2.09
18.64
30.5
17.0
e9/l
261.1
260.1
0.50
4990
47939
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
18
14
12.90
18.55
1.7
3.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
121
502
2.44
18.44
3.1
2.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5076
49191
2.09
18.36
30.6
17.0
g/l
133.5
134.5
5.40
5031
48522
(3011412) CD3 cells [#/volume] in Blood
102
391
2.64
18.32
3.0
2.4
e9/l
1.3
1.2
0.33
66
240
(3048929) Epstein Barr virus Ab [Presence] in Serum
240
1302
1.88
18.32
1.3
1.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
229
1228
1.90
18.12
1.8
1.6
titre
560.0
310.8
—
10
63
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
110
441
2.53
18.04
2.6
2.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
134
588
2.31
18.02
4.0
2.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
538
3637
1.53
17.98
4.7
3.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
179
884
2.06
17.93
1.5
1.3
e6/l
54.6
24.7
0.44
131
697
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
194
987
2.00
17.90
3.2
2.0
g/l
37.9
38.1
0.16
179
857
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
179
885
2.06
17.87
1.5
1.4
e6/l
300.6
1433.8
2.00
141
735
(3009542) Hematocrit [Volume Fraction] of Blood
4335
40602
1.40
17.66
22.6
12.2
%
39.3
39.7
2.72
3214
30662
(3029937) Albumin [Presence] in Urine by Test strip
1390
11169
1.33
17.47
4.7
3.8
estimate
0.0
0.0
2.12
543
3840
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
205
1073
1.95
17.44
3.5
2.2
g/l
0.8
0.9
0.24
188
939
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
171
841
2.07
17.33
3.4
3.8
%
57.0
56.7
0.09
171
841
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
82
289
2.87
17.31
2.3
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
138
625
2.24
17.24
1.6
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
362
2251
1.65
17.23
1.1
1.1
titre
53.5
212.0
—
10
59
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
80
279
2.90
17.21
3.0
2.6
e6/l
593.3
510.0
0.85
63
236
(3025159) Blasts/100 leukocytes in Blood
463
3072
1.56
16.81
4.3
4.2
%
0.0
0.4
1.17
123
686
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
176
885
2.02
16.80
1.7
1.4
nmol/l
0.3
0.4
1.20
138
682
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
316
1910
1.70
16.75
3.8
3.1
kpa
5.2
5.2
0.03
297
1773
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
304
1820
1.71
16.69
3.7
3.0
mmol/l
2.1
1.8
0.84
225
1362
(3007566) Smooth muscle Ab [Titer] in Serum
206
1102
1.90
16.44
1.2
1.3
titre
74.2
162.9
0.87
12
98
(40763590) HLA-DQ beta [Type]
18
17
10.62
16.43
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
458
3047
1.55
16.42
2.5
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
313
1899
1.69
16.36
1.8
1.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
77
271
2.87
16.32
3.2
2.7
e9/l
0.2
0.2
0.20
63
234
(44806118)
100
403
2.51
16.26
2.1
1.4
—
—
—
0
0
(44790049)
100
403
2.51
16.26
2.1
1.4
—
—
—
0
0
(44790047)
100
403
2.51
16.26
2.1
1.4
—
—
—
0
0
(44790048)
100
403
2.51
16.26
2.1
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
310
1880
1.69
16.23
3.8
3.1
ph
7.4
7.4
0.13
60
257
(36660697) Celiac disease serology panel - Serum
531
3670
1.50
15.92
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
84
314
2.70
15.91
2.4
2.0
%
12.7
14.4
0.49
52
152
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
141
666
2.15
15.91
1.2
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
18
18
10.03
15.80
1.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
32
62
5.19
15.77
2.0
1.6
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
448
2999
1.54
15.61
1.8
1.3
iu/l
30.8
30.2
0.12
368
2621
(3000060) B lymphocytes [#/volume] in Blood
46
122
3.80
15.35
2.1
2.2
e6/l
226.4
145.4
0.57
28
69
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
45
118
3.84
15.25
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1467
12065
1.30
15.19
1.6
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
587
4180
1.46
15.10
22.7
20.3
inr
1.2
1.2
0.43
77
645
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1024
8018
1.34
15.01
1.3
1.3
u/ml
9.1
11.7
0.66
399
3304
(3017181) Myelocytes/100 leukocytes in Blood
489
3366
1.50
14.93
4.5
4.1
%
1.0
0.8
0.54
138
856
(3017817) Protein [Mass] in Urine collected for unspecified duration
70
246
2.87
14.91
2.9
2.3
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
40
98
4.11
14.87
1.5
1.5
ug/l
0.4
0.4
0.03
23
63
(3024980) IgG subclass 4 [Mass/volume] in Serum
139
671
2.10
14.85
1.9
1.6
g/l
0.7
0.7
0.04
100
507
(3022145) Colonoscopy Study observation
644
4690
1.43
14.66
1.3
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
147
730
2.04
14.57
2.5
2.1
g/l
128.3
130.2
0.39
112
518
(3021440) Promyelocytes/100 leukocytes in Blood
470
3228
1.50
14.50
4.4
4.2
%
0.1
0.2
0.42
130
793
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
129
614
2.13
14.31
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
679
5018
1.41
14.20
1.7
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
46
129
3.59
14.18
1.2
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
99
424
2.36
14.16
1.8
1.3
g/l
3.0
2.9
0.08
69
294
(3024139) IgG subclass 3 [Mass/volume] in Serum
99
424
2.36
14.16
1.8
1.3
g/l
0.3
0.4
1.20
68
290
(3000494) Fungus identified in Specimen by Culture
652
4788
1.41
14.14
1.6
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
168
888
1.92
13.95
1.4
1.2
mmol/l
3.7
3.7
0.15
157
833
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
187
1025
1.85
13.89
2.6
2.2
ug/l
216.5
610.4
1.15
172
939
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1060
8430
1.32
13.83
1.3
1.3
iu/ml
26.1
32.7
0.67
341
2710
(3002179) Metamyelocytes/100 leukocytes in Blood
451
3105
1.50
13.74
4.3
4.0
%
0.8
0.5
1.19
109
638
(3027135) IgG subclass 1 [Mass/volume] in Serum
98
425
2.33
13.64
1.8
1.3
g/l
6.5
6.7
0.19
67
294
(3045142) Bone marrow Pathology biopsy report
89
370
2.43
13.61
1.9
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
67
242
2.79
13.60
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4047
37906
1.30
13.51
26.5
14.5
g/l
331.5
331.8
0.96
4019
37619
(4062490)
96
417
2.33
13.32
1.9
1.4
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
19
9
21.18
13.31
1.6
2.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
98
430
2.30
13.29
1.2
1.2
u/l
69.5
55.1
0.96
84
285
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
127
619
2.08
13.27
1.2
1.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
372
2477
1.54
13.26
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
136
681
2.02
13.21
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
136
681
2.02
13.21
1.4
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
195
1103
1.80
13.10
1.2
1.3
titre
448.0
840.2
—
5
49
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
389
2624
1.52
13.06
2.3
2.1
ug/l
7.3
6.2
0.36
334
2290
(21494434) Karyotype in Bone marrow
71
271
2.64
12.98
1.3
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
117
559
2.12
12.89
2.3
2.6
umol/l
31.7
34.6
0.73
98
487
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4589
43836
1.38
12.88
5.2
4.3
mmol/l
2.8
2.9
9.13
4326
40541
(3048689) Calprotectin [Mass/mass] in Stool
748
5705
1.36
12.84
2.2
2.3
ug/g
110.1
116.8
0.28
607
4457
(3015171) Extractable nuclear Ab [Units/volume] in Serum
301
1925
1.60
12.80
1.3
1.3
u/ml
0.4
1.3
1.81
32
176
(3014148) Varicella zoster virus Ab [Titer] in Serum
120
581
2.09
12.78
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
157
838
1.90
12.69
1.6
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
41
115
3.59
12.67
33.1
33.4
ug/l
7.2
7.3
0.23
36
104
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
133
673
2.00
12.57
1.5
1.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
18
9
20.06
12.44
1.7
2.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
466
3309
1.45
12.11
1.6
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
90
399
2.28
11.95
1.7
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
128
651
1.99
11.94
2.0
2.0
nmol/l
0.8
0.8
0.30
109
557
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
301
1958
1.57
11.92
1.6
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
179
1019
1.78
11.80
1.5
1.3
mg/l
472.4
492.7
0.31
168
972
(3004451) EKG impression Narrative
40
116
3.47
11.78
1.3
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
73
299
2.46
11.59
1.2
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
19
30
6.35
11.54
3.7
2.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
39
113
3.47
11.51
4.7
2.9
ng/l
101.2
146.1
0.30
23
45
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
100
473
2.14
11.36
1.4
1.4
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
92
421
2.21
11.35
1.5
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
192
1137
1.71
11.05
2.5
2.0
ug/l
2.5
2.0
0.23
172
1015
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
116
588
1.99
10.96
1.5
1.4
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
133
710
1.90
10.81
2.0
1.4
ug/l
1.9
3.8
3.69
98
620
(3017704) Immunofixation for Urine
44
146
3.03
10.47
2.7
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
413
2947
1.44
10.44
1.5
1.3
u/ml
164.4
189.1
0.39
388
2748
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3284
30361
1.22
10.44
3.4
3.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
30
78
3.86
10.37
1.3
1.2
pmol/l
628.0
275.6
1.09
19
60
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61
243
2.53
10.31
1.7
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
21
41
5.14
10.30
1.5
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
443
3216
1.41
10.18
2.9
2.4
ml/min/173m2
63.2
70.4
3.47
190
1191
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
36
108
3.35
10.11
2.0
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4325
41244
1.28
10.10
4.2
3.5
mmol/l
1.3
1.2
17.28
4055
38035
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
172
1015
1.72
10.06
2.2
1.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
74
326
2.29
10.04
1.3
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
176
1050
1.70
9.90
2.5
2.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4501
43168
1.31
9.89
4.7
3.9
mmol/l
4.7
4.9
13.87
4248
40198
(3051651) Icteric interference index of Serum or Plasma
55
214
2.59
9.77
6.9
2.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
100
502
2.01
9.75
1.7
1.5
iu/ml
24.2
22.2
—
6
25
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
230
1475
1.59
9.73
2.0
1.8
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
83
391
2.14
9.59
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
66
283
2.35
9.55
2.9
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
37
118
3.15
9.44
2.0
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
106
551
1.94
9.38
4.0
3.1
nmol/l
0.8
0.8
0.85
87
417
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
97
489
2.00
9.37
1.3
1.2
u/l
91.1
35.8
1.01
89
429
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
90
443
2.05
9.28
1.7
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
59
245
2.42
9.18
1.0
1.1
nmol/l
4.1
13.0
0.61
12
48
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
18
34
5.31
9.15
2.4
2.8
mg/l
1.3
1.1
0.12
11
22
(3020891) Body temperature
207
1315
1.60
9.13
6.3
4.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
47
175
2.70
9.13
1.6
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
101
524
1.95
9.00
1.6
1.4
—
—
—
0
0
(4281824)
108
574
1.90
8.97
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1102
9247
1.24
8.89
1.6
1.5
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
57
237
2.42
8.85
1.5
1.5
u/l
5.5
5.6
0.05
40
201
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
40
139
2.89
8.83
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
78
371
2.12
8.83
5.9
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4465
42901
1.28
8.78
4.6
3.9
mmol/l
1.5
1.5
17.88
4200
39796
(3013512) EKG study
1300
11145
1.22
8.50
3.9
3.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
203
1307
1.58
8.48
1.1
1.1
u/ml
4.8
6.3
0.27
23
177
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
62
274
2.28
8.42
1.3
1.4
nmol/l
1.3
1.4
0.28
57
243
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
173
1077
1.63
8.32
1.2
1.3
u/ml
34.3
40.9
0.25
20
122
(40768446) Kidney Pathology biopsy report
32
102
3.15
8.21
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
82
409
2.02
8.21
2.4
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
55
234
2.36
8.15
1.8
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
387
5171
0.73
8.13
4.7
4.0
%
32.4
32.7
0.26
283
3539
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
65
298
2.20
8.10
1.3
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
43
164
2.64
8.01
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
87
449
1.95
7.93
1.3
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
16
31
5.17
7.92
14.6
6.4
mmol/l
5.2
6.1
0.53
16
31
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
44
171
2.59
7.90
1.7
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
61
278
2.21
7.73
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
82
419
1.97
7.70
1.4
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
18
40
4.51
7.64
4.3
5.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
17
36
4.73
7.63
1.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
11
6
18.37
7.59
1.2
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
44
175
2.53
7.56
1.7
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
193
2.45
7.55
1.6
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
46
187
2.47
7.55
1.4
1.3
nmol/l
127.7
132.5
0.37
46
187
(42529406) Shigella sp [Presence] in Stool by Culture
190
1241
1.55
7.50
1.2
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
66
315
2.11
7.47
1.2
1.2
titre
70.0
212.5
—
9
72
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
74
369
2.02
7.45
2.5
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
51
219
2.34
7.44
2.0
2.1
%
10.6
11.3
0.49
51
219
(3000492) Spirometry study
529
4144
1.31
7.43
1.5
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
54
238
2.28
7.42
1.3
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
21
54
3.90
7.42
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1054
8960
1.22
7.36
4.5
3.9
kg/l
1.0
1.0
0.30
162
1288
(3014765) Yersinia sp identified in Stool by Organism specific culture
188
1237
1.54
7.20
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
58
268
2.18
7.14
1.7
1.5
u/l
6.2
5.7
0.10
33
129
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
23
66
3.50
6.98
1.7
1.3
ng/l
76.4
100.1
0.40
23
66
(4212803)
16
35
4.58
6.92
1.2
1.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
155
985
1.59
6.92
5.4
3.9
mmol/l
3.8
3.8
0.52
144
936
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
22
62
3.56
6.85
1.3
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
182
1205
1.53
6.79
3.0
2.9
g/l
0.2
0.3
0.48
88
444
(3030313) Adrenal Ab [Titer] in Serum
17
40
4.26
6.74
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
185
1233
1.52
6.70
1.2
1.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
31
110
2.83
6.67
4.0
1.6
ug/l
2.8
2.0
0.46
25
56
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
69
351
1.98
6.62
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
219
1520
1.46
6.51
1.7
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
115
689
1.68
6.51
2.8
2.4
ug/min
63.6
72.8
0.16
78
391
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
846
7117
1.23
6.48
1.7
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
140
884
1.60
6.45
1.6
1.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
54
254
2.14
6.40
2.4
1.9
—
1.9
—
0
18
(3039162) Centromere protein B Ab [Units/volume] in Serum
105
617
1.72
6.38
1.2
1.3
u/ml
63.2
52.9
—
5
48
(1761482) Bacteria [#/volume] in Urine by Culture
133
833
1.61
6.34
4.3
4.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
9
5
18.03
6.26
2.2
2.0
%
8.4
6.4
—
9
5
(3042733) HLA Ab [Presence] in Serum
25
82
3.06
6.18
4.0
5.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
194
2.28
6.11
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
97
566
1.73
6.07
1.2
1.1
iu/ml
69.7
15929.8
0.56
24
152
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
73
391
1.88
6.05
1.3
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
283
2085
1.38
6.04
2.8
2.1
u/l
4710.1
4623.4
0.01
100
818
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
98
576
1.71
5.98
1.9
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
194
1343
1.46
5.88
1.3
1.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
27
96
2.82
5.82
6.2
3.6
%
52.4
52.5
0.01
27
91
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
62
320
1.95
5.76
1.5
1.3
u/ml
1.8
1.0
0.25
26
141
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
411
3223
1.30
5.75
2.4
2.4
au/ml
19.3
24.4
0.53
22
218
(3044941) Cell count panel - Synovial fluid
98
584
1.69
5.71
1.7
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
380
2961
1.31
5.58
1.3
1.3
au/ml
51.7
47.4
0.10
12
137
(3024891) Influenza virus A+B Ag [Presence] in Specimen
163
1102
1.49
5.58
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
197
1389
1.43
5.45
1.2
1.3
u/ml
29.5
40.5
0.30
14
103
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
23
78
2.96
5.40
4.5
4.1
u/l
36.8
95.5
—
5
27
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
103
633
1.64
5.36
1.3
1.2
u/ml
3.6
3.9
0.06
31
213
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
14
34
4.13
5.35
1.5
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
60
317
1.90
5.24
2.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
60
317
1.90
5.24
2.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
60
317
1.90
5.24
2.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
972
8451
1.18
5.17
1.9
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
14
35
4.01
5.16
1.3
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
40
183
2.19
5.14
1.4
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
64
348
1.85
5.13
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
64
348
1.85
5.13
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
64
349
1.84
5.08
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
64
350
1.84
5.04
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
64
350
1.84
5.04
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
205
2.11
5.00
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
64
351
1.83
5.00
1.1
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
25
93
2.70
5.00
1.0
1.2
%
99.5
97.2
0.19
25
93
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
25
93
2.70
5.00
1.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
63
344
1.84
4.99
3.5
4.0
mmol/l
7.0
6.9
0.13
54
281
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
33
142
2.33
4.90
1.2
1.1
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
44
214
2.07
4.87
1.6
2.2
%
103.7
102.2
0.08
39
197
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
50
255
1.97
4.86
1.7
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
50
255
1.97
4.86
1.2
1.0
u/l
0.9
1.1
2.66
16
109
(3044927) Protein electrophoresis panel - Urine
56
297
1.90
4.86
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
191
1369
1.41
4.86
4.1
3.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
44
215
2.06
4.81
1.7
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
9
10
9.01
4.78
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
57
306
1.87
4.78
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
43
209
2.07
4.77
1.7
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
38
176
2.17
4.77
1.2
1.2
g/l
0.3
0.3
0.70
31
147
(40768443) Skin Pathology biopsy report
253
1905
1.34
4.76
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
97
607
1.61
4.74
1.2
1.1
%
120.3
118.5
0.19
80
551
(3033923) Metanephrine [Moles/time] in 24 hour Urine
20
68
2.95
4.70
1.1
1.1
umol/24h
118.9
0.7
—
6
34
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
56
303
1.86
4.59
1.2
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
47
240
1.97
4.58
1.4
1.5
u/ml
26.6
19.8
—
8
49
(4010399)
371
2963
1.27
4.54
1.5
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
151
1051
1.45
4.54
2.6
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
200
1466
1.38
4.49
1.7
1.9
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
29
123
2.37
4.47
2.4
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
32
143
2.25
4.39
1.7
2.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
132
901
1.48
4.39
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
96
613
1.58
4.35
1.3
1.2
u/ml
5.7
3.8
0.56
41
261
(4027681)
51
273
1.88
4.34
1.3
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
42
211
2.00
4.30
1.1
1.1
u/l
63.4
18.7
0.47
23
166
(3004809) Band form neutrophils/100 leukocytes in Blood
90
568
1.59
4.29
4.8
3.3
%
1.5
1.4
0.08
76
453
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
42
212
1.99
4.25
1.1
1.1
u/l
119.9
77.2
0.58
28
173
(3033705) Calcium.ionized [Moles/volume] in Venous blood
58
326
1.79
4.24
2.5
2.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
71
424
1.68
4.21
3.1
2.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
16
51
3.14
4.20
6.8
5.9
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
16
51
3.14
4.20
2.9
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
91
579
1.58
4.20
1.2
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
255
1.89
4.19
1.1
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
47
248
1.90
4.19
1.4
1.6
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
27
4.08
4.16
1.4
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
30
134
2.25
4.14
3.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
106
702
1.52
4.11
1.7
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
48
257
1.88
4.10
1.1
1.0
—
—
—
0
0
(4306422)
96
623
1.55
4.08
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
21
80
2.63
4.05
1.7
2.4
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
36
175
2.06
4.04
1.9
1.5
nmol/l
1.1
1.3
0.72
30
137
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
62
361
1.73
4.04
1.2
1.3
titre
—
—
—
0
0
(1002224) Polysomnography panel
238
1824
1.32
4.02
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
51
281
1.82
4.00
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
34
163
2.09
3.96
1.1
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
18
64
2.82
3.95
1.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
18
64
2.82
3.95
1.6
1.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
15
48
3.13
3.92
1.1
1.2
—
—
—
0
0
(4094501)
142
1008
1.42
3.89
1.1
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
171
1254
1.38
3.88
1.2
1.3
u/ml
1.5
5.0
0.93
12
138
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
54
306
1.77
3.88
2.6
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
415
4991
0.82
3.80
1.3
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
266
2088
1.29
3.79
2.4
2.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
101
675
1.51
3.78
1.3
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
172
1269
1.37
3.77
1.3
1.3
u/ml
30.1
6.5
0.73
20
231
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
53
302
1.76
3.75
1.7
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
34
167
2.04
3.74
1.3
1.6
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
8
12
6.67
3.67
1.9
2.7
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
16
56
2.86
3.62
6.7
5.8
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
24
104
2.31
3.58
1.1
1.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
42
228
1.85
3.49
1.2
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
376
3104
1.23
3.49
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
32
158
2.03
3.49
2.8
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
21
87
2.42
3.46
1.1
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
34
173
1.97
3.42
2.4
2.3
min
496.8
495.7
0.03
28
130
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
612
5317
1.17
3.26
4.8
4.5
ug/l
2.0
2.6
1.49
544
4751
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
179
1362
1.33
3.25
1.6
1.6
iu/ml
0.1
5.0
0.53
47
260
(3032868) Hemoglobin electrophoresis panel in Blood
13
43
3.03
3.24
1.5
1.5
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
30
149
2.02
3.24
2.7
1.8
mmol/l
9.1
9.5
0.31
22
116
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
102
707
1.45
3.24
1.1
1.1
u/ml
3.7
3.6
0.02
53
350
(3000330) Specific gravity of Urine by Test strip
233
1839
1.28
3.23
3.4
3.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
68
433
1.58
3.21
2.1
2.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
11
33
3.34
3.19
1.3
1.2
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
21
91
2.31
3.16
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
79
2.41
3.13
1.2
1.2
—
—
—
0
0
(3025315) Body weight
9
20
4.51
3.11
6.2
3.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
28
139
2.02
3.05
6.1
3.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
92
635
1.46
3.01
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
115
827
1.40
3.01
1.7
1.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
67
433
1.55
3.00
1.2
1.1
%
95.8
95.6
0.02
59
413
(3035880) pH of Pleural fluid
28
140
2.01
2.99
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
60
379
1.59
2.96
1.1
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
23
107
2.15
2.96
1.2
1.1
—
—
—
0
0
(4034850)
182
1409
1.30
2.95
9.8
8.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
109
2.11
2.84
1.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
39
223
1.75
2.81
1.3
1.4
titre
92.0
675.4
—
5
13
(3029075) Extractable nuclear Ab panel - Serum
25
124
2.02
2.75
1.0
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
14
5.01
2.72
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1756
16459
1.10
2.72
2.9
2.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
6
10
6.01
2.69
3.0
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
28
146
1.92
2.69
3.5
2.3
—
—
—
0
0
(4268621)
65
429
1.52
2.68
2.5
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
42
249
1.69
2.68
1.6
1.5
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
19
4.22
2.67
1.1
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
10
32
3.13
2.64
1.4
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
134
1012
1.33
2.63
1.2
1.3
u/ml
1.0
2.5
—
7
79
(3019977) pH of Arterial blood
29
155
1.88
2.60
3.2
3.1
ph
7.4
7.4
0.55
13
61
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
25
127
1.97
2.59
3.3
2.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
15
4.67
2.59
1.1
1.1
nmol/l
327.3
284.9
—
7
15
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
163
1.85
2.57
1.9
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
163
1.85
2.57
1.9
1.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
52
330
1.58
2.56
1.2
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
160
1244
1.30
2.56
4.2
3.3
mmol/l
25.1
25.0
0.18
152
1156
(3004716) Salmonella sp identified in Stool by Organism specific culture
289
2406
1.21
2.55
1.4
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
34
193
1.77
2.53
3.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
34
193
1.77
2.53
3.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
34
193
1.77
2.53
3.3
1.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
393
4567
0.85
2.52
1.6
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
52
332
1.57
2.50
1.1
1.1
nmol/l
415.7
385.5
0.47
40
298
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
34
194
1.76
2.50
3.3
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
20
95
2.11
2.48
1.6
1.3
umol/l
16.3
17.5
0.78
20
83
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
16
4.38
2.47
6.6
12.3
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
39
2.82
2.47
5.7
6.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
48
302
1.59
2.46
3.9
4.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
55
358
1.54
2.45
1.3
1.1
mg/l
33.0
34.4
0.15
46
301
(3015183) Erythrocyte sedimentation rate
42
256
1.65
2.44
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
30
166
1.81
2.44
1.8
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
13
51
2.55
2.44
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
486
4252
1.16
2.41
4.1
4.0
%
24.1
21.3
3.03
225
2001
(3034426) Prothrombin time (PT)
27
145
1.87
2.41
1.3
1.2
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
12
5.00
2.40
1.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
61
894
0.68
2.39
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
89
1220
0.72
2.39
1.4
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
58
385
1.51
2.37
5.3
4.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
125
1.92
2.35
3.0
4.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
23
118
1.95
2.35
5.6
3.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
69
476
1.46
2.34
1.1
1.1
—
4.3
—
0
7
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
53
346
1.54
2.34
1.2
1.1
mg/l
215.9
225.6
0.22
46
302
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
36
214
1.69
2.31
1.3
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
207
2530
0.81
2.31
1.4
1.5
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
11
41
2.69
2.27
2.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
35
208
1.69
2.26
1.2
1.1
miu/ml
1609.0
1476.7
0.29
35
208
(40758292) HTLV I+II Ab panel - Serum
15
66
2.28
2.24
1.7
1.4
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
9
5.56
2.21
3.8
2.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
28
157
1.79
2.21
2.0
2.6
umol/l
178.3
166.1
0.06
17
85
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
71
499
1.43
2.21
1.1
1.1
g/l
1.5
1.5
0.09
66
450
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
21
107
1.97
2.20
1.1
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
49
320
1.54
2.18
1.5
1.4
e6/l
1476.7
2865.7
1.47
37
233
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
12
48
2.50
2.18
1.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
44
282
1.57
2.13
1.0
1.0
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
44
282
1.57
2.13
1.3
1.1
ratio
1.1
1.0
1.05
18
99
(3004775) Volume in Urine collected for unspecified duration
38
235
1.62
2.13
2.3
2.3
ml
613.7
650.2
0.22
30
160
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
35
212
1.66
2.12
1.1
1.0
%
96.3
89.6
0.69
24
162
(3014891) Appearance of Pleural fluid
10
37
2.71
2.10
1.7
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
218
1804
1.22
2.10
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
119
918
1.30
2.08
1.8
1.7
e6/l
7980.9
10777.0
0.57
87
672
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
158
1264
1.26
2.08
1.3
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
15
69
2.18
2.04
1.7
2.4
mmol/l
8.3
7.0
—
8
35
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
25
141
1.78
1.96
1.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
175
2134
0.81
1.96
1.5
1.5
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
5
11
4.55
1.94
1.0
1.0
%
3.4
2.5
—
5
11
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
28
164
1.71
1.94
1.3
1.4
pmol/l
101.4
251.9
0.38
17
50
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
16
3.75
1.93
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
294
2525
1.17
1.91
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
100
766
1.31
1.87
2.9
3.4
u/ml
1536.3
759.0
0.34
94
699
(3028433) Virus identified in Specimen by Culture
24
136
1.77
1.86
1.2
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
59
2.21
1.84
1.4
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
13
59
2.21
1.84
1.2
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
39
253
1.55
1.83
1.1
1.4
promille
1.1
1.3
0.40
33
195
(3038177) Helicobacter pylori Ab [Presence] in Serum
106
822
1.30
1.82
1.2
1.2
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.17
1.82
3.8
3.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
27
160
1.69
1.81
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
60
427
1.41
1.80
1.1
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
7
23
3.05
1.80
1.4
2.0
umol/l
70.1
49.6
—
7
23
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
16
80
2.00
1.79
1.2
1.0
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
8
29
2.76
1.79
1.1
1.4
—
—
—
0
0
(4038314)
5
13
3.85
1.71
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
18
96
1.88
1.70
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
15
282
0.53
1.70
1.2
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
74
556
1.34
1.62
1.2
1.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
50
352
1.42
1.62
1.3
1.4
mmol/l
12.7
12.4
0.07
21
64
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
12
56
2.15
1.61
3.2
2.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
10
43
2.33
1.60
1.0
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
45
312
1.45
1.58
3.2
2.5
mg/l
21.6
36.9
0.31
34
216
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
98
769
1.28
1.58
1.5
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
18
99
1.82
1.57
2.5
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
22
129
1.71
1.56
3.2
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
183
1540
1.20
1.56
2.5
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
160
1.63
1.55
3.7
2.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
160
1.63
1.55
3.7
2.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
46
322
1.43
1.55
1.1
1.1
iu/ml
11.0
9.8
0.09
16
84
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
163
1358
1.21
1.54
1.5
1.3
—
—
—
0
0
(4024509)
28
433
0.64
1.54
1.7
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
7
27
2.59
1.51
11.9
4.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
21
2.86
1.50
8.0
6.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
82
634
1.30
1.50
1.9
2.2
umol/l
5.9
5.5
0.14
64
460
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
79
1.90
1.49
1.1
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
162
1.61
1.49
3.7
2.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
57
418
1.37
1.48
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
24
147
1.64
1.47
1.3
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
7
28
2.50
1.45
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
366
3267
1.13
1.45
4.2
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
571
5225
1.10
1.45
1.6
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
140
1.65
1.44
1.3
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
52
2.12
1.44
1.1
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
41
286
1.44
1.42
1.6
1.4
e6/l
35275.1
74698.9
0.67
25
164
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
69
526
1.32
1.41
1.9
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
43
304
1.42
1.40
1.3
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
43
304
1.42
1.40
2.5
2.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
46
2.18
1.39
3.8
2.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
29
2.42
1.39
2.7
3.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
38
263
1.45
1.38
1.6
1.4
ug/l
13.4
7.4
0.44
33
228
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
5
17
2.94
1.36
1.6
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
165
1398
1.19
1.34
2.0
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
25
159
1.58
1.34
1.1
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
41
570
0.72
1.33
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
38
266
1.43
1.31
4.9
1.5
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
39
275
1.42
1.30
1.2
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
129
1.63
1.29
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
528
5745
0.91
1.28
2.0
2.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
59
447
1.32
1.28
1.7
1.5
—
1160.0
—
0
10
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
38
268
1.42
1.27
1.5
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
49
362
1.36
1.26
4.5
3.4
%
58.5
55.3
0.44
36
249
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
253
0.59
1.23
2.4
1.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
25
163
1.54
1.22
1.0
1.1
ng/l
128.2
321.1
—
5
33
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
5
19
2.63
1.21
2.0
1.5
—
0.0
—
0
6
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
19
2.63
1.21
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
66
513
1.29
1.21
1.9
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
85
1051
0.81
1.19
1.7
1.7
—
—
—
0
0
(3019225) pH of Specimen
444
4059
1.10
1.19
8.6
3.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
26
2.31
1.18
1.5
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
8
38
2.11
1.18
2.1
1.9
umol/l
1.3
1.4
—
8
30
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
25
165
1.52
1.17
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
40
290
1.38
1.17
1.6
1.6
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
1.0
—
1.1
—
0
13
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
39
2.05
1.15
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
303
2719
1.12
1.15
3.4
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
87
1.73
1.15
5.8
2.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
115
1370
0.84
1.13
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
98
807
1.22
1.12
1.1
1.1
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
7
31
2.26
1.10
2.7
3.1
mg/l
20.9
22.0
—
7
31
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
7
31
2.26
1.10
1.1
1.4
%
76.5
68.6
—
7
25
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
26
176
1.48
1.10
1.3
1.6
—
1273502.5
—
0
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
202
1773
1.14
1.10
1.7
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
115
1365
0.84
1.09
1.3
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
65
513
1.27
1.09
1.9
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
539
4996
1.09
1.08
1.5
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
23
152
1.52
1.08
1.3
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
116
1372
0.84
1.06
1.3
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
13
74
1.76
1.06
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
281
3122
0.89
1.06
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
391
3576
1.10
1.06
1.7
1.8
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
116
1371
0.84
1.06
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
65
516
1.26
1.04
1.9
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
97
806
1.21
1.03
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
34
2.06
1.02
1.1
1.1
umol/24h
53.2
1.7
—
7
34
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
60
1.84
1.02
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
65
518
1.26
1.02
1.9
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
146
1687
0.86
1.02
1.4
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
14
83
1.69
1.01
1.4
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
14
83
1.69
1.01
1.4
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
14
83
1.69
1.01
1.4
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
48
1.88
1.00
1.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
99
1.62
0.99
1.4
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
16
99
1.62
0.99
1.8
1.4
%
36.2
39.4
—
9
68
(3024522) Salmonella sp identified in Specimen by Organism specific culture
65
520
1.25
0.99
1.9
1.4
—
—
—
0
0
(3001686) Cold agglutinin [Titer] in Serum or Plasma
13
76
1.71
0.98
1.2
1.4
—
110.9
—
0
11
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
5
23
2.17
0.98
3.0
1.7
%
26.2
62.8
—
5
13
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
190
1677
1.14
0.98
1.4
1.3
miu/ml
221.8
229.6
0.11
91
843
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
4.4
—
0
24
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
15
92
1.63
0.97
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
474
5106
0.92
0.97
1.9
1.9
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
59
469
1.26
0.96
1.6
1.7
%
51.1
53.7
0.15
31
294
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
62
1.78
0.94
3.3
5.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
62
1.78
0.94
1.6
2.8
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
19
125
1.52
0.93
1.1
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
127
1471
0.86
0.93
1.4
1.5
—
—
—
0
0
(4198724)
23
158
1.46
0.93
1.7
1.8
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
55
1.82
0.92
1.4
1.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
6
29
2.07
0.89
1.2
1.0
u/l
7.5
18.0
—
6
29
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
12
71
1.69
0.88
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
37
484
0.76
0.88
1.6
2.1
mg/l
27.3
23.3
—
8
134
(3017732) Neutrophils [#/volume] in Blood
341
3135
1.09
0.87
2.4
2.6
e9/l
4.3
4.0
1.35
278
2526
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
23
161
1.43
0.86
1.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
16
240
0.67
0.85
8.8
12.1
nmol/l
538.2
868.6
1.98
16
229
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
14
88
1.59
0.84
1.0
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
22
154
1.43
0.83
2.0
2.0
%
159.5
152.1
0.16
22
140
(3025018) Bordetella pertussis Ab [Titer] in Serum
38
292
1.30
0.82
1.3
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
11
65
1.69
0.82
2.1
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
24
330
0.73
0.81
1.3
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1055
10118
1.05
0.81
1.5
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
81
1.61
0.81
5.5
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
81
1.61
0.81
5.4
2.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
101
1172
0.86
0.79
1.4
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
305
2804
1.09
0.79
1.5
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
24
173
1.39
0.78
1.0
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
238
2168
1.10
0.76
1.5
1.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
0.7
—
0
16
(3024869) Neuronal Ab [Presence] in Serum
10
59
1.70
0.75
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
116
1013
1.15
0.75
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
98
1133
0.86
0.75
1.4
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
17
244
0.70
0.75
10.6
17.3
nmol/l
974.7
5365.3
0.59
17
236
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
24
2.08
0.74
1.0
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
98
1131
0.86
0.73
1.4
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
25
2.00
0.72
3.0
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
45
362
1.25
0.71
1.5
1.6
%
48.8
35.1
1.06
23
217
(3019174) dRVVT (LA screen)
7
40
1.75
0.71
1.1
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
26
1.92
0.70
2.8
1.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
97
844
1.15
0.68
3.3
3.3
mg/l
27.8
25.0
0.30
62
506
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
83
714
1.17
0.67
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
5
92
0.54
0.67
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
103
1.46
0.64
1.8
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
149
1343
1.11
0.62
1.3
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
23
173
1.33
0.61
1.1
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
8
51
1.57
0.60
1.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
51
1.57
0.60
6.5
3.1
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
8
53
1.51
0.58
3.6
5.7
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
13
89
1.46
0.58
1.2
1.1
%
79.0
81.1
—
7
19
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
54
1.48
0.57
5.1
7.6
—
—
—
0
0
(44813793)
41
343
1.20
0.50
1.0
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
24
302
0.79
0.49
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
19
246
0.77
0.49
1.8
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
7
46
1.52
0.48
2.9
2.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
47
1.49
0.47
1.3
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
49
1.43
0.46
1.0
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
27
330
0.82
0.44
1.1
1.0
u/ml
0.5
0.9
0.65
11
76
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
51
1.37
0.44
1.1
1.0
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
148
1.28
0.43
1.0
1.1
%
92.2
94.9
0.14
11
68
(44816559) Phosphatidylethanol [Mass/volume] in Blood
82
735
1.12
0.43
1.1
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
71
632
1.13
0.42
1.3
1.3
mmol/l
7.2
7.2
0.02
52
477
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
330
3138
1.06
0.41
2.9
2.9
ug/l
0.7
0.7
1.08
231
1993
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
150
1.27
0.40
1.1
1.1
%
85.3
91.8
0.48
11
68
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.6
—
24.7
—
0
18
(3042517) Benzodiazepines panel - Urine
5
35
1.43
0.39
1.8
2.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
516
4970
1.04
0.39
1.5
1.7
%
1.4
1.4
0.26
469
4443
(3047007) Chlamydophila sp Ab [Presence] in Serum
78
703
1.11
0.38
1.3
1.2
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
3.5
—
0
6
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
12
90
1.33
0.35
1.3
1.1
%
69.9
74.2
—
7
19
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
45
1.33
0.33
1.2
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
45
1.33
0.33
8.2
3.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
85
777
1.10
0.33
1.3
1.5
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
89
0.67
0.33
1.8
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
24
285
0.84
0.32
1.4
1.4
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
32
370
0.86
0.32
1.2
1.2
—
57.3
—
0
23
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
12
92
1.31
0.31
1.1
1.3
%
99.6
108.1
0.46
12
84
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
100
925
1.08
0.31
1.6
1.4
u/l
30.9
28.6
0.23
86
765
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
193
1828
1.06
0.31
1.9
1.7
mg/l
4.6
3.6
0.54
147
1265
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
211
1.19
0.31
1.6
2.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
23
193
1.19
0.30
1.4
1.8
—
—
—
0
0
(44806420)
10
75
1.33
0.30
2.1
2.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
11
84
1.31
0.30
1.9
2.1
umol/l
11.5
15.6
1.08
11
84
(3007916) DNA double strand Ab [Titer] in Serum
8
62
1.29
0.28
1.8
1.4
—
150.4
—
0
5
(3023511) Choriogonadotropin [Units/volume] in Urine
117
1096
1.07
0.28
1.3
1.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
24
206
1.17
0.26
2.2
1.7
u/field
2.1
3.9
0.76
18
141
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
106
993
1.07
0.26
1.1
1.1
u/ml
1.7
1.1
0.21
46
377
(3020650) Glucose [Presence] in Urine
15
123
1.22
0.25
1.3
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
126
0.79
0.24
11.3
11.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
36
323
1.12
0.22
1.1
1.1
u/ml
0.8
2.2
0.55
18
91
(3044009) aPTT.lupus sensitive (LA screen)
5
40
1.25
0.22
1.2
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
155
1624
0.95
0.22
1.7
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
199
0.85
0.21
2.3
3.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
34
377
0.90
0.21
1.6
1.6
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.2
—
0
8
(3010726) Horse dander IgE Ab [Units/volume] in Serum
89
838
1.06
0.20
1.1
1.1
u/ml
1.6
1.8
0.07
24
196
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
12.5
—
0
9
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
13
108
1.20
0.20
1.1
1.1
u/ml
89.5
54.6
0.59
13
102
(3037556) Urate [Mass/volume] in Serum or Plasma
9
111
0.81
0.20
1.0
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
76
713
1.07
0.20
1.6
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
109
1.19
0.18
1.1
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
23
204
1.13
0.18
1.1
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
27
300
0.90
0.18
1.1
1.0
u/ml
0.2
2.1
—
7
42
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
91
1.21
0.17
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
28
310
0.90
0.17
1.1
1.2
—
—
—
0
0
(4146454)
34
310
1.10
0.17
2.9
2.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
76
718
1.06
0.17
1.8
2.9
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
31
340
0.91
0.16
1.2
1.2
—
5.6
—
0
26
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
226
1.11
0.15
1.0
1.0
ng/l
737.4
746.2
0.03
17
147
(3003888) Timothy IgE Ab [Units/volume] in Serum
94
898
1.05
0.15
1.0
1.1
u/ml
3.6
5.4
0.76
55
461
(3009466) Valproate [Moles/volume] in Serum or Plasma
51
480
1.06
0.13
4.7
5.2
umol/l
339.8
372.5
1.06
44
413
(3020491) Glucose [Moles/volume] in Blood
30
276
1.09
0.13
1.7
1.9
mmol/l
7.2
6.4
0.51
24
190
(3010144) Erythrocytes [#/volume] in Synovial fluid
38
354
1.07
0.13
1.5
1.4
e6/l
49999.7
40209.6
0.09
26
245
(4133840)
9
109
0.83
0.13
1.2
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
10
85
1.18
0.12
1.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
229
1.09
0.12
1.0
1.0
ng/l
38.7
48.5
0.58
18
151
(3041806) Other cells [#/volume] in Blood by Manual count
16
143
1.12
0.11
1.6
1.6
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
11
126
0.87
0.11
2.2
3.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
126
0.87
0.11
1.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
89
859
1.04
0.10
1.0
1.1
u/ml
1.2
1.1
0.03
38
357
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(4211845)
20
217
0.92
0.09
3.4
3.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
66
685
0.96
0.09
1.1
1.1
u/ml
2.1
3.4
0.71
27
266
(3014051) Protein [Presence] in Urine by Test strip
98
952
1.03
0.08
1.8
1.9
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(44806071)
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
112
1149
0.97
0.08
1.8
3.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
24
224
1.07
0.08
1.0
1.0
ng/l
246.8
356.7
1.36
17
152
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
73
0.82
0.07
1.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
112
0.89
0.07
1.4
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
84
0.83
0.07
1.4
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
170
1674
1.02
0.06
1.6
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
152
1545
0.98
0.06
1.6
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
191
1936
0.99
0.05
1.8
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
90
1.11
0.05
3.1
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
463
4666
0.99
0.05
1.6
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
111
1.08
0.04
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
127
1287
0.99
0.04
1.7
2.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
12
129
0.93
0.03
1.3
1.6
ug/l
9.3
8.1
0.39
12
129
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
14
149
0.94
0.03
1.0
1.0
—
5.3
—
0
17
(3004616) Nuclear Ab [Presence] in Serum
56
570
0.98
0.02
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
168
1667
1.01
0.02
1.6
2.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
60
610
0.98
0.02
1.1
1.1
u/ml
2.2
0.3
0.42
15
129
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
113
1.06
0.01
1.1
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
114
1.05
0.00
1.1
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
503
5038
1.00
0.00
7.7
5.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
48
474
1.01
0.00
1.0
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
74
734
1.01
0.00
1.1
1.1
u/ml
5.1
3.2
0.39
28
268
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
104
0.96
0.00
1.1
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
14
144
0.97
0.00
2.0
2.3
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
113
0.97
0.00
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
33
326
1.01
0.00
1.2
1.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
37
373
0.99
0.00
1.5
1.5
mmol/l
7.7
7.7
0.04
24
234
(3028300) Cannabinoids [Presence] in Urine
169
1693
1.00
0.00
1.6
2.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
30
301
1.00
0.00
3.1
2.0
u/field
4.2
2.3
—
9
122
(3027008) Opiates [Presence] in Urine
169
1689
1.00
0.00
1.6
2.1
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005067) clonazePAM [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
66.2
—
0
8
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
9
98
0.92
0.00
2.4
2.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
89
1.01
0.00
3.6
1.9
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
60
1.00
0.00
1.2
1.4
%
15.8
28.6
—
6
48
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
76
0.92
0.00
1.6
1.6
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
6
0.00
0.00
0.0
1.2
—
66.1
—
0
6
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.2
—
40.1
—
0
5
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
5.3
—
0.2
—
0
7
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
24
240
1.00
0.00
1.3
1.3
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
50
1.00
0.00
1.8
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
8
88
0.91
0.00
1.5
1.4
%
35.0
24.1
—
8
78
Mortality – FinRegistry
↥Association
Association between endpoint E4_ENDOMETPOSTOP and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ENDOMETPOSTOP | 1.389 [1.25, 1.54] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.251 |
During the follow-up period (1.1.1998 — 31.12.2019), 2313 out of 15139 females with E4_ENDOMETPOSTOP died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_ENDOMETPOSTOP | 1.759 [1.53, 2.02] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 856 out of 3787 males with E4_ENDOMETPOSTOP died.
Mortality risk
Mortality risk for people of age
years, who have E4_ENDOMETPOSTOP.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.106% | 0.304% |
| 5 | 0.716% | 1.862% |
| 10 | 2.022% | 4.208% |
| 15 | 3.956% | 8.218% |
| 20 | 6.946% | 13.828% |
Relationships between endpoints
↥Index endpoint: E4_ENDOMETPOSTOP – Postprocedural endocrine and metabolic disorders, not elsewhere classified
GWS hits: 7
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data